INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3157, 20431, 'Trimipramine', 'Concomitant use of ethanol and a tricyclic antidepressant (TCA) may result altered TCA plasma levels and efficacy, and additive impairment of motor skills, especially driving skills.  Acute ethanol ingestion may inhibit TCA metabolism, while chronic ingestion of large amounts of ethanol may induce hepatic TCA metabolism.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c4d8ec115c2300c4357d104dda10f06e0c00226761bf39a189ca4d0ed49e0c259d2ffba5055c9b5a0446b1be32620deb508a31a683765d0162cda066eae79c5f534a346717a1c1330ff420d05af6888b40b5a66f1d5b280a5da5b170d5d63f94f922c6b35ef9ac5bcd7820b0de980cb320661d0cf56681d97eeadd4f43d9ae818009767d3be9f3e164f46e7', NULL, X'789c55905d6ec4300884af328fad14ed1d567b855e80b5c91a151bcb9054b97ddd6cd59f4718f866e0662d5995a016d89c612b380a355350cb20c49074249534eb90cc7db0fbd7f4cbdbedfa8a4a076667d30069f0e08cd94757f24a50de59fd24f1ba4aa2742c4f6ece12b233a47692517902a775b5b0017f17555fc0de3909a91ec84376698f6fe9025cd316fc13754aec21d6ce3cd28adc25ce209583eea6e275c1471165a432accd737e77a6b1d27830a8dad6c2ff3ee1c9cb5b6214ee1473f13ff6f20926a7759d');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3158, 3849, 'Valerian', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c1d8ecb0dc3300c4357e100fdcc50f4de4bd101545b49d4d896612901b27deddc04f03d528f1474d1844c07aa3a171772866966e8045f1875a1962968d25902789a38b88df0f97a5f29b8ec0c9abb6937e0630c29089abf52c845cb59ddd8b6e423a118e55442371a25146ebb6e063bcc392372edb00d914abc6b83e44ad272c7c7e86f8bf3b82ffd3729ab94f93240543bc2a259bd1bb64a4a76fb0301fd51b0');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3160, 3029, 'Valproic acid', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c1d8ecb0dc3300c4357e100fdcc50f4de4bd101545b49d4d896612901b27deddc04f03d528f1474d1844c07aa3a171772866966e8045f1875a1962968d25902789a38b88df0f97a5f29b8ec0c9abb6937e0630c29089abf52c845cb59ddd8b6e423a118e55442371a25146ebb6e063bcc392372edb00d914abc6b83e44ad272c7c7e86f8bf3b82ffd3729ab94f93240543bc2a259bd1bb64a4a76fb0301fd51b0');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3161, 3031, 'Valproic acid', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c1d8ecb0dc3300c4357e100fdcc50f4de4bd101545b49d4d896612901b27deddc04f03d528f1474d1844c07aa3a171772866966e8045f1875a1962968d25902789a38b88df0f97a5f29b8ec0c9abb6937e0630c29089abf52c845cb59ddd8b6e423a118e55442371a25146ebb6e063bcc392372edb00d914abc6b83e44ad272c7c7e86f8bf3b82ffd3729ab94f93240543bc2a259bd1bb64a4a76fb0301fd51b0');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3162, 12047, 'Valproic acid', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c1d8ecb0dc3300c4357e100fdcc50f4de4bd101545b49d4d896612901b27deddc04f03d528f1474d1844c07aa3a171772866966e8045f1875a1962968d25902789a38b88df0f97a5f29b8ec0c9abb6937e0630c29089abf52c845cb59ddd8b6e423a118e55442371a25146ebb6e063bcc392372edb00d914abc6b83e44ad272c7c7e86f8bf3b82ffd3729ab94f93240543bc2a259bd1bb64a4a76fb0301fd51b0');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3163, 12121, 'Valproic acid', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c1d8ecb0dc3300c4357e100fdcc50f4de4bd101545b49d4d896612901b27deddc04f03d528f1474d1844c07aa3a171772866966e8045f1875a1962968d25902789a38b88df0f97a5f29b8ec0c9abb6937e0630c29089abf52c845cb59ddd8b6e423a118e55442371a25146ebb6e063bcc392372edb00d914abc6b83e44ad272c7c7e86f8bf3b82ffd3729ab94f93240543bc2a259bd1bb64a4a76fb0301fd51b0');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3164, 17129, 'Valproic acid', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c1d8ecb0dc3300c4357e100fdcc50f4de4bd101545b49d4d896612901b27deddc04f03d528f1474d1844c07aa3a171772866966e8045f1875a1962968d25902789a38b88df0f97a5f29b8ec0c9abb6937e0630c29089abf52c845cb59ddd8b6e423a118e55442371a25146ebb6e063bcc392372edb00d914abc6b83e44ad272c7c7e86f8bf3b82ffd3729ab94f93240543bc2a259bd1bb64a4a76fb0301fd51b0');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3165, 17258, 'Valproic acid', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c1d8ecb0dc3300c4357e100fdcc50f4de4bd101545b49d4d896612901b27deddc04f03d528f1474d1844c07aa3a171772866966e8045f1875a1962968d25902789a38b88df0f97a5f29b8ec0c9abb6937e0630c29089abf52c845cb59ddd8b6e423a118e55442371a25146ebb6e063bcc392372edb00d914abc6b83e44ad272c7c7e86f8bf3b82ffd3729ab94f93240543bc2a259bd1bb64a4a76fb0301fd51b0');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3166, 17262, 'Valproic acid', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c1d8ecb0dc3300c4357e100fdcc50f4de4bd101545b49d4d896612901b27deddc04f03d528f1474d1844c07aa3a171772866966e8045f1875a1962968d25902789a38b88df0f97a5f29b8ec0c9abb6937e0630c29089abf52c845cb59ddd8b6e423a118e55442371a25146ebb6e063bcc392372edb00d914abc6b83e44ad272c7c7e86f8bf3b82ffd3729ab94f93240543bc2a259bd1bb64a4a76fb0301fd51b0');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3167, 17264, 'Valproic acid', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c1d8ecb0dc3300c4357e100fdcc50f4de4bd101545b49d4d896612901b27deddc04f03d528f1474d1844c07aa3a171772866966e8045f1875a1962968d25902789a38b88df0f97a5f29b8ec0c9abb6937e0630c29089abf52c845cb59ddd8b6e423a118e55442371a25146ebb6e063bcc392372edb00d914abc6b83e44ad272c7c7e86f8bf3b82ffd3729ab94f93240543bc2a259bd1bb64a4a76fb0301fd51b0');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3168, 22532, 'Valproic acid', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c1d8ecb0dc3300c4357e100fdcc50f4de4bd101545b49d4d896612901b27deddc04f03d528f1474d1844c07aa3a171772866966e8045f1875a1962968d25902789a38b88df0f97a5f29b8ec0c9abb6937e0630c29089abf52c845cb59ddd8b6e423a118e55442371a25146ebb6e063bcc392372edb00d914abc6b83e44ad272c7c7e86f8bf3b82ffd3729ab94f93240543bc2a259bd1bb64a4a76fb0301fd51b0');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3169, 26703, 'Valproic acid', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c1d8ecb0dc3300c4357e100fdcc50f4de4bd101545b49d4d896612901b27deddc04f03d528f1474d1844c07aa3a171772866966e8045f1875a1962968d25902789a38b88df0f97a5f29b8ec0c9abb6937e0630c29089abf52c845cb59ddd8b6e423a118e55442371a25146ebb6e063bcc392372edb00d914abc6b83e44ad272c7c7e86f8bf3b82ffd3729ab94f93240543bc2a259bd1bb64a4a76fb0301fd51b0');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3170, 29770, 'Valproic acid', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c1d8ecb0dc3300c4357e100fdcc50f4de4bd101545b49d4d896612901b27deddc04f03d528f1474d1844c07aa3a171772866966e8045f1875a1962968d25902789a38b88df0f97a5f29b8ec0c9abb6937e0630c29089abf52c845cb59ddd8b6e423a118e55442371a25146ebb6e063bcc392372edb00d914abc6b83e44ad272c7c7e86f8bf3b82ffd3729ab94f93240543bc2a259bd1bb64a4a76fb0301fd51b0');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3172, 2066, 'Verapamil', 'Verapamil may increase the blood concentrations and intoxicating effects of ethanol.  The exact mechanism of interaction is unknown but may involve verapamil inhibition of ethanol metabolism.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c0dcad10dc0200805c055de049da52b50259104c108eafaf5fbeea514b60ce4644aae38920d9b270deaa288e64b2b3e46f165c17a4b3a68bb5490166fae972c561f296ecf0fef571ecc', NULL, X'789c458e510ec2300c43afe213ec3488ff34cb58449ba0361be3f66408c1aff5fcecab747a50d38a462fa871171a825805a5bacf6037168b4ea16e03647352e187722676832c8b700cf8028995cceb045cb22e0771a00967a8a39d4016738e4f137460b3bbf9d350b6f8aeef5e77c1fefba4b66ad10ffff7a733a8784de9f406d35047aa');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3173, 6622, 'Verapamil', 'Verapamil may increase the blood concentrations and intoxicating effects of ethanol.  The exact mechanism of interaction is unknown but may involve verapamil inhibition of ethanol metabolism.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c0dcad10dc0200805c055de049da52b50259104c108eafaf5fbeea514b60ce4644aae38920d9b270deaa288e64b2b3e46f165c17a4b3a68bb5490166fae972c561f296ecf0fef571ecc', NULL, X'789c458e510ec2300c43afe213ec3488ff34cb58449ba0361be3f66408c1aff5fcecab747a50d38a462fa871171a825805a5bacf6037168b4ea16e03647352e187722676832c8b700cf8028995cceb045cb22e0771a00967a8a39d4016738e4f137460b3bbf9d350b6f8aeef5e77c1fefba4b66ad10ffff7a733a8784de9f406d35047aa');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3174, 6625, 'Verapamil', 'Verapamil may increase the blood concentrations and intoxicating effects of ethanol.  The exact mechanism of interaction is unknown but may involve verapamil inhibition of ethanol metabolism.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c0dcad10dc0200805c055de049da52b50259104c108eafaf5fbeea514b60ce4644aae38920d9b270deaa288e64b2b3e46f165c17a4b3a68bb5490166fae972c561f296ecf0fef571ecc', NULL, X'789c458e510ec2300c43afe213ec3488ff34cb58449ba0361be3f66408c1aff5fcecab747a50d38a462fa871171a825805a5bacf6037168b4ea16e03647352e187722676832c8b700cf8028995cceb045cb22e0771a00967a8a39d4016738e4f137460b3bbf9d350b6f8aeef5e77c1fefba4b66ad10ffff7a733a8784de9f406d35047aa');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3175, 6627, 'Verapamil', 'Verapamil may increase the blood concentrations and intoxicating effects of ethanol.  The exact mechanism of interaction is unknown but may involve verapamil inhibition of ethanol metabolism.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c0dcad10dc0200805c055de049da52b50259104c108eafaf5fbeea514b60ce4644aae38920d9b270deaa288e64b2b3e46f165c17a4b3a68bb5490166fae972c561f296ecf0fef571ecc', NULL, X'789c458e510ec2300c43afe213ec3488ff34cb58449ba0361be3f66408c1aff5fcecab747a50d38a462fa871171a825805a5bacf6037168b4ea16e03647352e187722676832c8b700cf8028995cceb045cb22e0771a00967a8a39d4016738e4f137460b3bbf9d350b6f8aeef5e77c1fefba4b66ad10ffff7a733a8784de9f406d35047aa');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3176, 12220, 'Verapamil', 'Verapamil may increase the blood concentrations and intoxicating effects of ethanol.  The exact mechanism of interaction is unknown but may involve verapamil inhibition of ethanol metabolism.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c0dcad10dc0200805c055de049da52b50259104c108eafaf5fbeea514b60ce4644aae38920d9b270deaa288e64b2b3e46f165c17a4b3a68bb5490166fae972c561f296ecf0fef571ecc', NULL, X'789c458e510ec2300c43afe213ec3488ff34cb58449ba0361be3f66408c1aff5fcecab747a50d38a462fa871171a825805a5bacf6037168b4ea16e03647352e187722676832c8b700cf8028995cceb045cb22e0771a00967a8a39d4016738e4f137460b3bbf9d350b6f8aeef5e77c1fefba4b66ad10ffff7a733a8784de9f406d35047aa');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3177, 12222, 'Verapamil', 'Verapamil may increase the blood concentrations and intoxicating effects of ethanol.  The exact mechanism of interaction is unknown but may involve verapamil inhibition of ethanol metabolism.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c0dcad10dc0200805c055de049da52b50259104c108eafaf5fbeea514b60ce4644aae38920d9b270deaa288e64b2b3e46f165c17a4b3a68bb5490166fae972c561f296ecf0fef571ecc', NULL, X'789c458e510ec2300c43afe213ec3488ff34cb58449ba0361be3f66408c1aff5fcecab747a50d38a462fa871171a825805a5bacf6037168b4ea16e03647352e187722676832c8b700cf8028995cceb045cb22e0771a00967a8a39d4016738e4f137460b3bbf9d350b6f8aeef5e77c1fefba4b66ad10ffff7a733a8784de9f406d35047aa');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3178, 15848, 'Verapamil', 'Verapamil may increase the blood concentrations and intoxicating effects of ethanol.  The exact mechanism of interaction is unknown but may involve verapamil inhibition of ethanol metabolism.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c0dcad10dc0200805c055de049da52b50259104c108eafaf5fbeea514b60ce4644aae38920d9b270deaa288e64b2b3e46f165c17a4b3a68bb5490166fae972c561f296ecf0fef571ecc', NULL, X'789c458e510ec2300c43afe213ec3488ff34cb58449ba0361be3f66408c1aff5fcecab747a50d38a462fa871171a825805a5bacf6037168b4ea16e03647352e187722676832c8b700cf8028995cceb045cb22e0771a00967a8a39d4016738e4f137460b3bbf9d350b6f8aeef5e77c1fefba4b66ad10ffff7a733a8784de9f406d35047aa');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3179, 19879, 'Verapamil', 'Verapamil may increase the blood concentrations and intoxicating effects of ethanol.  The exact mechanism of interaction is unknown but may involve verapamil inhibition of ethanol metabolism.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c0dcad10dc0200805c055de049da52b50259104c108eafaf5fbeea514b60ce4644aae38920d9b270deaa288e64b2b3e46f165c17a4b3a68bb5490166fae972c561f296ecf0fef571ecc', NULL, X'789c458e510ec2300c43afe213ec3488ff34cb58449ba0361be3f66408c1aff5fcecab747a50d38a462fa871171a825805a5bacf6037168b4ea16e03647352e187722676832c8b700cf8028995cceb045cb22e0771a00967a8a39d4016738e4f137460b3bbf9d350b6f8aeef5e77c1fefba4b66ad10ffff7a733a8784de9f406d35047aa');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3180, 19880, 'Verapamil', 'Verapamil may increase the blood concentrations and intoxicating effects of ethanol.  The exact mechanism of interaction is unknown but may involve verapamil inhibition of ethanol metabolism.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c0dcad10dc0200805c055de049da52b50259104c108eafaf5fbeea514b60ce4644aae38920d9b270deaa288e64b2b3e46f165c17a4b3a68bb5490166fae972c561f296ecf0fef571ecc', NULL, X'789c458e510ec2300c43afe213ec3488ff34cb58449ba0361be3f66408c1aff5fcecab747a50d38a462fa871171a825805a5bacf6037168b4ea16e03647352e187722676832c8b700cf8028995cceb045cb22e0771a00967a8a39d4016738e4f137460b3bbf9d350b6f8aeef5e77c1fefba4b66ad10ffff7a733a8784de9f406d35047aa');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3181, 21019, 'Verapamil', 'Verapamil may increase the blood concentrations and intoxicating effects of ethanol.  The exact mechanism of interaction is unknown but may involve verapamil inhibition of ethanol metabolism.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c0dcad10dc0200805c055de049da52b50259104c108eafaf5fbeea514b60ce4644aae38920d9b270deaa288e64b2b3e46f165c17a4b3a68bb5490166fae972c561f296ecf0fef571ecc', NULL, X'789c458e510ec2300c43afe213ec3488ff34cb58449ba0361be3f66408c1aff5fcecab747a50d38a462fa871171a825805a5bacf6037168b4ea16e03647352e187722676832c8b700cf8028995cceb045cb22e0771a00967a8a39d4016738e4f137460b3bbf9d350b6f8aeef5e77c1fefba4b66ad10ffff7a733a8784de9f406d35047aa');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3182, 21106, 'Verapamil', 'Verapamil may increase the blood concentrations and intoxicating effects of ethanol.  The exact mechanism of interaction is unknown but may involve verapamil inhibition of ethanol metabolism.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c0dcad10dc0200805c055de049da52b50259104c108eafaf5fbeea514b60ce4644aae38920d9b270deaa288e64b2b3e46f165c17a4b3a68bb5490166fae972c561f296ecf0fef571ecc', NULL, X'789c458e510ec2300c43afe213ec3488ff34cb58449ba0361be3f66408c1aff5fcecab747a50d38a462fa871171a825805a5bacf6037168b4ea16e03647352e187722676832c8b700cf8028995cceb045cb22e0771a00967a8a39d4016738e4f137460b3bbf9d350b6f8aeef5e77c1fefba4b66ad10ffff7a733a8784de9f406d35047aa');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3183, 21107, 'Verapamil', 'Verapamil may increase the blood concentrations and intoxicating effects of ethanol.  The exact mechanism of interaction is unknown but may involve verapamil inhibition of ethanol metabolism.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c0dcad10dc0200805c055de049da52b50259104c108eafaf5fbeea514b60ce4644aae38920d9b270deaa288e64b2b3e46f165c17a4b3a68bb5490166fae972c561f296ecf0fef571ecc', NULL, X'789c458e510ec2300c43afe213ec3488ff34cb58449ba0361be3f66408c1aff5fcecab747a50d38a462fa871171a825805a5bacf6037168b4ea16e03647352e187722676832c8b700cf8028995cceb045cb22e0771a00967a8a39d4016738e4f137460b3bbf9d350b6f8aeef5e77c1fefba4b66ad10ffff7a733a8784de9f406d35047aa');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3184, 21108, 'Verapamil', 'Verapamil may increase the blood concentrations and intoxicating effects of ethanol.  The exact mechanism of interaction is unknown but may involve verapamil inhibition of ethanol metabolism.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c0dcad10dc0200805c055de049da52b50259104c108eafaf5fbeea514b60ce4644aae38920d9b270deaa288e64b2b3e46f165c17a4b3a68bb5490166fae972c561f296ecf0fef571ecc', NULL, X'789c458e510ec2300c43afe213ec3488ff34cb58449ba0361be3f66408c1aff5fcecab747a50d38a462fa871171a825805a5bacf6037168b4ea16e03647352e187722676832c8b700cf8028995cceb045cb22e0771a00967a8a39d4016738e4f137460b3bbf9d350b6f8aeef5e77c1fefba4b66ad10ffff7a733a8784de9f406d35047aa');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3185, 21109, 'Verapamil', 'Verapamil may increase the blood concentrations and intoxicating effects of ethanol.  The exact mechanism of interaction is unknown but may involve verapamil inhibition of ethanol metabolism.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c0dcad10dc0200805c055de049da52b50259104c108eafaf5fbeea514b60ce4644aae38920d9b270deaa288e64b2b3e46f165c17a4b3a68bb5490166fae972c561f296ecf0fef571ecc', NULL, X'789c458e510ec2300c43afe213ec3488ff34cb58449ba0361be3f66408c1aff5fcecab747a50d38a462fa871171a825805a5bacf6037168b4ea16e03647352e187722676832c8b700cf8028995cceb045cb22e0771a00967a8a39d4016738e4f137460b3bbf9d350b6f8aeef5e77c1fefba4b66ad10ffff7a733a8784de9f406d35047aa');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3186, 29139, 'Verapamil', 'Verapamil may increase the blood concentrations and intoxicating effects of ethanol.  The exact mechanism of interaction is unknown but may involve verapamil inhibition of ethanol metabolism.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c0dcad10dc0200805c055de049da52b50259104c108eafaf5fbeea514b60ce4644aae38920d9b270deaa288e64b2b3e46f165c17a4b3a68bb5490166fae972c561f296ecf0fef571ecc', NULL, X'789c458e510ec2300c43afe213ec3488ff34cb58449ba0361be3f66408c1aff5fcecab747a50d38a462fa871171a825805a5bacf6037168b4ea16e03647352e187722676832c8b700cf8028995cceb045cb22e0771a00967a8a39d4016738e4f137460b3bbf9d350b6f8aeef5e77c1fefba4b66ad10ffff7a733a8784de9f406d35047aa');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3187, 29141, 'Verapamil', 'Verapamil may increase the blood concentrations and intoxicating effects of ethanol.  The exact mechanism of interaction is unknown but may involve verapamil inhibition of ethanol metabolism.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c0dcad10dc0200805c055de049da52b50259104c108eafaf5fbeea514b60ce4644aae38920d9b270deaa288e64b2b3e46f165c17a4b3a68bb5490166fae972c561f296ecf0fef571ecc', NULL, X'789c458e510ec2300c43afe213ec3488ff34cb58449ba0361be3f66408c1aff5fcecab747a50d38a462fa871171a825805a5bacf6037168b4ea16e03647352e187722676832c8b700cf8028995cceb045cb22e0771a00967a8a39d4016738e4f137460b3bbf9d350b6f8aeef5e77c1fefba4b66ad10ffff7a733a8784de9f406d35047aa');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3188, 29182, 'Verapamil', 'Verapamil may increase the blood concentrations and intoxicating effects of ethanol.  The exact mechanism of interaction is unknown but may involve verapamil inhibition of ethanol metabolism.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c0dcad10dc0200805c055de049da52b50259104c108eafaf5fbeea514b60ce4644aae38920d9b270deaa288e64b2b3e46f165c17a4b3a68bb5490166fae972c561f296ecf0fef571ecc', NULL, X'789c458e510ec2300c43afe213ec3488ff34cb58449ba0361be3f66408c1aff5fcecab747a50d38a462fa871171a825805a5bacf6037168b4ea16e03647352e187722676832c8b700cf8028995cceb045cb22e0771a00967a8a39d4016738e4f137460b3bbf9d350b6f8aeef5e77c1fefba4b66ad10ffff7a733a8784de9f406d35047aa');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3189, 2066, 'Verapamil', 'Consumption of large quantities of grapefruit juice may be associated with significantly increased plasma concentrations of oral verapamil.  The mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grain', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c458f516ec3300c43afc20bb418b0ee00432fb08ffdec53719444832d7b96bc22b79fd2a1e82f253e92d7aa364a73a98aba20535f193f83d4c585edd0d64e8d973ec4f13d24310aed981864569390f38c9bf8069355659114debc433475268b63cb648590aa2656ef7464ddc1b553c62f079e8ae433f0b9059cd3462a562016904d267994bb7e7d5cde5ef0fa7e39159eff9317e9e6a7165dc2e934d57cb72a3c58eb70dc28674c3b1277a7d0532dad0e9d0dadb345a1e3f939d1ce7fdc076552');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3190, 6622, 'Verapamil', 'Consumption of large quantities of grapefruit juice may be associated with significantly increased plasma concentrations of oral verapamil.  The mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grain', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c458f516ec3300c43afc20bb418b0ee00432fb08ffdec53719444832d7b96bc22b79fd2a1e82f253e92d7aa364a73a98aba20535f193f83d4c585edd0d64e8d973ec4f13d24310aed981864569390f38c9bf8069355659114debc433475268b63cb648590aa2656ef7464ddc1b553c62f079e8ae433f0b9059cd3462a562016904d267994bb7e7d5cde5ef0fa7e39159eff9317e9e6a7165dc2e934d57cb72a3c58eb70dc28674c3b1277a7d0532dad0e9d0dadb345a1e3f939d1ce7fdc076552');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3191, 6625, 'Verapamil', 'Consumption of large quantities of grapefruit juice may be associated with significantly increased plasma concentrations of oral verapamil.  The mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grain', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c458f516ec3300c43afc20bb418b0ee00432fb08ffdec53719444832d7b96bc22b79fd2a1e82f253e92d7aa364a73a98aba20535f193f83d4c585edd0d64e8d973ec4f13d24310aed981864569390f38c9bf8069355659114debc433475268b63cb648590aa2656ef7464ddc1b553c62f079e8ae433f0b9059cd3462a562016904d267994bb7e7d5cde5ef0fa7e39159eff9317e9e6a7165dc2e934d57cb72a3c58eb70dc28674c3b1277a7d0532dad0e9d0dadb345a1e3f939d1ce7fdc076552');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3192, 6627, 'Verapamil', 'Consumption of large quantities of grapefruit juice may be associated with significantly increased plasma concentrations of oral verapamil.  The mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grain', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c458f516ec3300c43afc20bb418b0ee00432fb08ffdec53719444832d7b96bc22b79fd2a1e82f253e92d7aa364a73a98aba20535f193f83d4c585edd0d64e8d973ec4f13d24310aed981864569390f38c9bf8069355659114debc433475268b63cb648590aa2656ef7464ddc1b553c62f079e8ae433f0b9059cd3462a562016904d267994bb7e7d5cde5ef0fa7e39159eff9317e9e6a7165dc2e934d57cb72a3c58eb70dc28674c3b1277a7d0532dad0e9d0dadb345a1e3f939d1ce7fdc076552');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3193, 12220, 'Verapamil', 'Consumption of large quantities of grapefruit juice may be associated with significantly increased plasma concentrations of oral verapamil.  The mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grain', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c458f516ec3300c43afc20bb418b0ee00432fb08ffdec53719444832d7b96bc22b79fd2a1e82f253e92d7aa364a73a98aba20535f193f83d4c585edd0d64e8d973ec4f13d24310aed981864569390f38c9bf8069355659114debc433475268b63cb648590aa2656ef7464ddc1b553c62f079e8ae433f0b9059cd3462a562016904d267994bb7e7d5cde5ef0fa7e39159eff9317e9e6a7165dc2e934d57cb72a3c58eb70dc28674c3b1277a7d0532dad0e9d0dadb345a1e3f939d1ce7fdc076552');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3194, 12222, 'Verapamil', 'Consumption of large quantities of grapefruit juice may be associated with significantly increased plasma concentrations of oral verapamil.  The mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grain', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c458f516ec3300c43afc20bb418b0ee00432fb08ffdec53719444832d7b96bc22b79fd2a1e82f253e92d7aa364a73a98aba20535f193f83d4c585edd0d64e8d973ec4f13d24310aed981864569390f38c9bf8069355659114debc433475268b63cb648590aa2656ef7464ddc1b553c62f079e8ae433f0b9059cd3462a562016904d267994bb7e7d5cde5ef0fa7e39159eff9317e9e6a7165dc2e934d57cb72a3c58eb70dc28674c3b1277a7d0532dad0e9d0dadb345a1e3f939d1ce7fdc076552');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3195, 15848, 'Verapamil', 'Consumption of large quantities of grapefruit juice may be associated with significantly increased plasma concentrations of oral verapamil.  The mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grain', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c458f516ec3300c43afc20bb418b0ee00432fb08ffdec53719444832d7b96bc22b79fd2a1e82f253e92d7aa364a73a98aba20535f193f83d4c585edd0d64e8d973ec4f13d24310aed981864569390f38c9bf8069355659114debc433475268b63cb648590aa2656ef7464ddc1b553c62f079e8ae433f0b9059cd3462a562016904d267994bb7e7d5cde5ef0fa7e39159eff9317e9e6a7165dc2e934d57cb72a3c58eb70dc28674c3b1277a7d0532dad0e9d0dadb345a1e3f939d1ce7fdc076552');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3196, 19879, 'Verapamil', 'Consumption of large quantities of grapefruit juice may be associated with significantly increased plasma concentrations of oral verapamil.  The mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grain', 'Moderate', '', 'DDInter', 0, X'789c4d90ed6dc3300c4457b901822e9025b2026351165b7d1822e5d499be24d002fd49e1f8f8740f32e16e0a9b4cc6092fb18231a9e2e4490735a9d032564da073488215c636baae76988c8e915169ee0c6a6305c91f76dfe43c9798a3fe4f9f4b36860d1c934fbf0bea17564f8b91ebda6c513015d2a13c57439a6b47f56cd50fe0f167fb6bf4f4abe914756f672af3171a27d9dc9ecc3c198292c3f9027f1f3c7ddd053871a350d317d72a7d0fe9f8581d2f9e9ef4369af82dbd43574adc6f6ee9804ad2a32496bd18769fee4892b36cabda856794589c77c756580d8727e28e45beb33acfa7721dc3ed34ec283e1bca51fef372dafb2d91bc21fbb239ec163b635a196aa4a21f3f3ff4a381', NULL, X'789c458f516ec3300c43afc20bb418b0ee00432fb08ffdec53719444832d7b96bc22b79fd2a1e82f253e92d7aa364a73a98aba20535f193f83d4c585edd0d64e8d973ec4f13d24310aed981864569390f38c9bf8069355659114debc433475268b63cb648590aa2656ef7464ddc1b553c62f079e8ae433f0b9059cd3462a562016904d267994bb7e7d5cde5ef0fa7e39159eff9317e9e6a7165dc2e934d57cb72a3c58eb70dc28674c3b1277a7d0532dad0e9d0dadb345a1e3f939d1ce7fdc076552');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3197, 19880, 'Verapamil', 'Consumption of large quantities of grapefruit juice may be associated with significantly increased plasma concentrations of oral verapamil.  The mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grain', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c458f516ec3300c43afc20bb418b0ee00432fb08ffdec53719444832d7b96bc22b79fd2a1e82f253e92d7aa364a73a98aba20535f193f83d4c585edd0d64e8d973ec4f13d24310aed981864569390f38c9bf8069355659114debc433475268b63cb648590aa2656ef7464ddc1b553c62f079e8ae433f0b9059cd3462a562016904d267994bb7e7d5cde5ef0fa7e39159eff9317e9e6a7165dc2e934d57cb72a3c58eb70dc28674c3b1277a7d0532dad0e9d0dadb345a1e3f939d1ce7fdc076552');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3198, 21019, 'Verapamil', 'Consumption of large quantities of grapefruit juice may be associated with significantly increased plasma concentrations of oral verapamil.  The mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grain', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c458f516ec3300c43afc20bb418b0ee00432fb08ffdec53719444832d7b96bc22b79fd2a1e82f253e92d7aa364a73a98aba20535f193f83d4c585edd0d64e8d973ec4f13d24310aed981864569390f38c9bf8069355659114debc433475268b63cb648590aa2656ef7464ddc1b553c62f079e8ae433f0b9059cd3462a562016904d267994bb7e7d5cde5ef0fa7e39159eff9317e9e6a7165dc2e934d57cb72a3c58eb70dc28674c3b1277a7d0532dad0e9d0dadb345a1e3f939d1ce7fdc076552');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3199, 21106, 'Verapamil', 'Consumption of large quantities of grapefruit juice may be associated with significantly increased plasma concentrations of oral verapamil.  The mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grain', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c458f516ec3300c43afc20bb418b0ee00432fb08ffdec53719444832d7b96bc22b79fd2a1e82f253e92d7aa364a73a98aba20535f193f83d4c585edd0d64e8d973ec4f13d24310aed981864569390f38c9bf8069355659114debc433475268b63cb648590aa2656ef7464ddc1b553c62f079e8ae433f0b9059cd3462a562016904d267994bb7e7d5cde5ef0fa7e39159eff9317e9e6a7165dc2e934d57cb72a3c58eb70dc28674c3b1277a7d0532dad0e9d0dadb345a1e3f939d1ce7fdc076552');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3200, 21107, 'Verapamil', 'Consumption of large quantities of grapefruit juice may be associated with significantly increased plasma concentrations of oral verapamil.  The mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grain', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c458f516ec3300c43afc20bb418b0ee00432fb08ffdec53719444832d7b96bc22b79fd2a1e82f253e92d7aa364a73a98aba20535f193f83d4c585edd0d64e8d973ec4f13d24310aed981864569390f38c9bf8069355659114debc433475268b63cb648590aa2656ef7464ddc1b553c62f079e8ae433f0b9059cd3462a562016904d267994bb7e7d5cde5ef0fa7e39159eff9317e9e6a7165dc2e934d57cb72a3c58eb70dc28674c3b1277a7d0532dad0e9d0dadb345a1e3f939d1ce7fdc076552');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3201, 21108, 'Verapamil', 'Consumption of large quantities of grapefruit juice may be associated with significantly increased plasma concentrations of oral verapamil.  The mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grain', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c458f516ec3300c43afc20bb418b0ee00432fb08ffdec53719444832d7b96bc22b79fd2a1e82f253e92d7aa364a73a98aba20535f193f83d4c585edd0d64e8d973ec4f13d24310aed981864569390f38c9bf8069355659114debc433475268b63cb648590aa2656ef7464ddc1b553c62f079e8ae433f0b9059cd3462a562016904d267994bb7e7d5cde5ef0fa7e39159eff9317e9e6a7165dc2e934d57cb72a3c58eb70dc28674c3b1277a7d0532dad0e9d0dadb345a1e3f939d1ce7fdc076552');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3202, 21109, 'Verapamil', 'Consumption of large quantities of grapefruit juice may be associated with significantly increased plasma concentrations of oral verapamil.  The mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grain', 'Moderate', '', 'DDInter', 0, X'789c4d90ed6dc3300c4457b901822e9025b2026351165b7d1822e5d499be24d002fd49e1f8f8740f32e16e0a9b4cc6092fb18231a9e2e4490735a9d032564da073488215c636baae76988c8e915169ee0c6a6305c91f76dfe43c9798a3fe4f9f4b36860d1c934fbf0bea17564f8b91ebda6c513015d2a13c57439a6b47f56cd50fe0f167fb6bf4f4abe914756f672af3171a27d9dc9ecc3c198292c3f9027f1f3c7ddd053871a350d317d72a7d0fe9f8581d2f9e9ef4369af82dbd43574adc6f6ee9804ad2a32496bd18769fee4892b36cabda856794589c77c756580d8727e28e45beb33acfa7721dc3ed34ec283e1bca51fef372dafb2d91bc21fbb239ec163b635a196aa4a21f3f3ff4a381', NULL, X'789c458f516ec3300c43afc20bb418b0ee00432fb08ffdec53719444832d7b96bc22b79fd2a1e82f253e92d7aa364a73a98aba20535f193f83d4c585edd0d64e8d973ec4f13d24310aed981864569390f38c9bf8069355659114debc433475268b63cb648590aa2656ef7464ddc1b553c62f079e8ae433f0b9059cd3462a562016904d267994bb7e7d5cde5ef0fa7e39159eff9317e9e6a7165dc2e934d57cb72a3c58eb70dc28674c3b1277a7d0532dad0e9d0dadb345a1e3f939d1ce7fdc076552');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3203, 29139, 'Verapamil', 'Consumption of large quantities of grapefruit juice may be associated with significantly increased plasma concentrations of oral verapamil.  The mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grain', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c458f516ec3300c43afc20bb418b0ee00432fb08ffdec53719444832d7b96bc22b79fd2a1e82f253e92d7aa364a73a98aba20535f193f83d4c585edd0d64e8d973ec4f13d24310aed981864569390f38c9bf8069355659114debc433475268b63cb648590aa2656ef7464ddc1b553c62f079e8ae433f0b9059cd3462a562016904d267994bb7e7d5cde5ef0fa7e39159eff9317e9e6a7165dc2e934d57cb72a3c58eb70dc28674c3b1277a7d0532dad0e9d0dadb345a1e3f939d1ce7fdc076552');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3204, 29141, 'Verapamil', 'Consumption of large quantities of grapefruit juice may be associated with significantly increased plasma concentrations of oral verapamil.  The mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grain', 'Moderate', '', 'DDInter', 0, X'789c4d90ed6dc3300c4457b901822e9025b2026351165b7d1822e5d499be24d002fd49e1f8f8740f32e16e0a9b4cc6092fb18231a9e2e4490735a9d032564da073488215c636baae76988c8e915169ee0c6a6305c91f76dfe43c9798a3fe4f9f4b36860d1c934fbf0bea17564f8b91ebda6c513015d2a13c57439a6b47f56cd50fe0f167fb6bf4f4abe914756f672af3171a27d9dc9ecc3c198292c3f9027f1f3c7ddd053871a350d317d72a7d0fe9f8581d2f9e9ef4369af82dbd43574adc6f6ee9804ad2a32496bd18769fee4892b36cabda856794589c77c756580d8727e28e45beb33acfa7721dc3ed34ec283e1bca51fef372dafb2d91bc21fbb239ec163b635a196aa4a21f3f3ff4a381', NULL, X'789c458f516ec3300c43afc20bb418b0ee00432fb08ffdec53719444832d7b96bc22b79fd2a1e82f253e92d7aa364a73a98aba20535f193f83d4c585edd0d64e8d973ec4f13d24310aed981864569390f38c9bf8069355659114debc433475268b63cb648590aa2656ef7464ddc1b553c62f079e8ae433f0b9059cd3462a562016904d267994bb7e7d5cde5ef0fa7e39159eff9317e9e6a7165dc2e934d57cb72a3c58eb70dc28674c3b1277a7d0532dad0e9d0dadb345a1e3f939d1ce7fdc076552');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3205, 29182, 'Verapamil', 'Consumption of large quantities of grapefruit juice may be associated with significantly increased plasma concentrations of oral verapamil.  The mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grain', 'Moderate', '', 'DDInter', 0, X'789c4d90ed6dc3300c4457b901822e9025b2026351165b7d1822e5d499be24d002fd49e1f8f8740f32e16e0a9b4cc6092fb18231a9e2e4490735a9d032564da073488215c636baae76988c8e915169ee0c6a6305c91f76dfe43c9798a3fe4f9f4b36860d1c934fbf0bea17564f8b91ebda6c513015d2a13c57439a6b47f56cd50fe0f167fb6bf4f4abe914756f672af3171a27d9dc9ecc3c198292c3f9027f1f3c7ddd053871a350d317d72a7d0fe9f8581d2f9e9ef4369af82dbd43574adc6f6ee9804ad2a32496bd18769fee4892b36cabda856794589c77c756580d8727e28e45beb33acfa7721dc3ed34ec283e1bca51fef372dafb2d91bc21fbb239ec163b635a196aa4a21f3f3ff4a381', NULL, X'789c458f516ec3300c43afc20bb418b0ee00432fb08ffdec53719444832d7b96bc22b79fd2a1e82f253e92d7aa364a73a98aba20535f193f83d4c585edd0d64e8d973ec4f13d24310aed981864569390f38c9bf8069355659114debc433475268b63cb648590aa2656ef7464ddc1b553c62f079e8ae433f0b9059cd3462a562016904d267994bb7e7d5cde5ef0fa7e39159eff9317e9e6a7165dc2e934d57cb72a3c58eb70dc28674c3b1277a7d0532dad0e9d0dadb345a1e3f939d1ce7fdc076552');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3206, 2066, 'Verapamil', 'Consumption of large quantities of grapefruit juice may be associated with significantly increased plasma concentrations of oral verapamil.  The mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grapefruit juice', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c458f516ec3300c43afc20bb418b0ee00432fb08ffdec53719444832d7b96bc22b79fd2a1e82f253e92d7aa364a73a98aba20535f193f83d4c585edd0d64e8d973ec4f13d24310aed981864569390f38c9bf8069355659114debc433475268b63cb648590aa2656ef7464ddc1b553c62f079e8ae433f0b9059cd3462a562016904d267994bb7e7d5cde5ef0fa7e39159eff9317e9e6a7165dc2e934d57cb72a3c58eb70dc28674c3b1277a7d0532dad0e9d0dadb345a1e3f939d1ce7fdc076552');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3207, 6622, 'Verapamil', 'Consumption of large quantities of grapefruit juice may be associated with significantly increased plasma concentrations of oral verapamil.  The mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grapefruit juice', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c458f516ec3300c43afc20bb418b0ee00432fb08ffdec53719444832d7b96bc22b79fd2a1e82f253e92d7aa364a73a98aba20535f193f83d4c585edd0d64e8d973ec4f13d24310aed981864569390f38c9bf8069355659114debc433475268b63cb648590aa2656ef7464ddc1b553c62f079e8ae433f0b9059cd3462a562016904d267994bb7e7d5cde5ef0fa7e39159eff9317e9e6a7165dc2e934d57cb72a3c58eb70dc28674c3b1277a7d0532dad0e9d0dadb345a1e3f939d1ce7fdc076552');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3208, 6625, 'Verapamil', 'Consumption of large quantities of grapefruit juice may be associated with significantly increased plasma concentrations of oral verapamil.  The mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grapefruit juice', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c458f516ec3300c43afc20bb418b0ee00432fb08ffdec53719444832d7b96bc22b79fd2a1e82f253e92d7aa364a73a98aba20535f193f83d4c585edd0d64e8d973ec4f13d24310aed981864569390f38c9bf8069355659114debc433475268b63cb648590aa2656ef7464ddc1b553c62f079e8ae433f0b9059cd3462a562016904d267994bb7e7d5cde5ef0fa7e39159eff9317e9e6a7165dc2e934d57cb72a3c58eb70dc28674c3b1277a7d0532dad0e9d0dadb345a1e3f939d1ce7fdc076552');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3209, 6627, 'Verapamil', 'Consumption of large quantities of grapefruit juice may be associated with significantly increased plasma concentrations of oral verapamil.  The mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grapefruit juice', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c458f516ec3300c43afc20bb418b0ee00432fb08ffdec53719444832d7b96bc22b79fd2a1e82f253e92d7aa364a73a98aba20535f193f83d4c585edd0d64e8d973ec4f13d24310aed981864569390f38c9bf8069355659114debc433475268b63cb648590aa2656ef7464ddc1b553c62f079e8ae433f0b9059cd3462a562016904d267994bb7e7d5cde5ef0fa7e39159eff9317e9e6a7165dc2e934d57cb72a3c58eb70dc28674c3b1277a7d0532dad0e9d0dadb345a1e3f939d1ce7fdc076552');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3210, 12220, 'Verapamil', 'Consumption of large quantities of grapefruit juice may be associated with significantly increased plasma concentrations of oral verapamil.  The mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grapefruit juice', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c458f516ec3300c43afc20bb418b0ee00432fb08ffdec53719444832d7b96bc22b79fd2a1e82f253e92d7aa364a73a98aba20535f193f83d4c585edd0d64e8d973ec4f13d24310aed981864569390f38c9bf8069355659114debc433475268b63cb648590aa2656ef7464ddc1b553c62f079e8ae433f0b9059cd3462a562016904d267994bb7e7d5cde5ef0fa7e39159eff9317e9e6a7165dc2e934d57cb72a3c58eb70dc28674c3b1277a7d0532dad0e9d0dadb345a1e3f939d1ce7fdc076552');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3211, 12222, 'Verapamil', 'Consumption of large quantities of grapefruit juice may be associated with significantly increased plasma concentrations of oral verapamil.  The mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grapefruit juice', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c458f516ec3300c43afc20bb418b0ee00432fb08ffdec53719444832d7b96bc22b79fd2a1e82f253e92d7aa364a73a98aba20535f193f83d4c585edd0d64e8d973ec4f13d24310aed981864569390f38c9bf8069355659114debc433475268b63cb648590aa2656ef7464ddc1b553c62f079e8ae433f0b9059cd3462a562016904d267994bb7e7d5cde5ef0fa7e39159eff9317e9e6a7165dc2e934d57cb72a3c58eb70dc28674c3b1277a7d0532dad0e9d0dadb345a1e3f939d1ce7fdc076552');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3212, 15848, 'Verapamil', 'Consumption of large quantities of grapefruit juice may be associated with significantly increased plasma concentrations of oral verapamil.  The mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grapefruit juice', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c458f516ec3300c43afc20bb418b0ee00432fb08ffdec53719444832d7b96bc22b79fd2a1e82f253e92d7aa364a73a98aba20535f193f83d4c585edd0d64e8d973ec4f13d24310aed981864569390f38c9bf8069355659114debc433475268b63cb648590aa2656ef7464ddc1b553c62f079e8ae433f0b9059cd3462a562016904d267994bb7e7d5cde5ef0fa7e39159eff9317e9e6a7165dc2e934d57cb72a3c58eb70dc28674c3b1277a7d0532dad0e9d0dadb345a1e3f939d1ce7fdc076552');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3213, 19879, 'Verapamil', 'Consumption of large quantities of grapefruit juice may be associated with significantly increased plasma concentrations of oral verapamil.  The mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grapefruit juice', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c458f516ec3300c43afc20bb418b0ee00432fb08ffdec53719444832d7b96bc22b79fd2a1e82f253e92d7aa364a73a98aba20535f193f83d4c585edd0d64e8d973ec4f13d24310aed981864569390f38c9bf8069355659114debc433475268b63cb648590aa2656ef7464ddc1b553c62f079e8ae433f0b9059cd3462a562016904d267994bb7e7d5cde5ef0fa7e39159eff9317e9e6a7165dc2e934d57cb72a3c58eb70dc28674c3b1277a7d0532dad0e9d0dadb345a1e3f939d1ce7fdc076552');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3214, 19880, 'Verapamil', 'Consumption of large quantities of grapefruit juice may be associated with significantly increased plasma concentrations of oral verapamil.  The mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grapefruit juice', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c458f516ec3300c43afc20bb418b0ee00432fb08ffdec53719444832d7b96bc22b79fd2a1e82f253e92d7aa364a73a98aba20535f193f83d4c585edd0d64e8d973ec4f13d24310aed981864569390f38c9bf8069355659114debc433475268b63cb648590aa2656ef7464ddc1b553c62f079e8ae433f0b9059cd3462a562016904d267994bb7e7d5cde5ef0fa7e39159eff9317e9e6a7165dc2e934d57cb72a3c58eb70dc28674c3b1277a7d0532dad0e9d0dadb345a1e3f939d1ce7fdc076552');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3215, 21019, 'Verapamil', 'Consumption of large quantities of grapefruit juice may be associated with significantly increased plasma concentrations of oral verapamil.  The mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grapefruit juice', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c458f516ec3300c43afc20bb418b0ee00432fb08ffdec53719444832d7b96bc22b79fd2a1e82f253e92d7aa364a73a98aba20535f193f83d4c585edd0d64e8d973ec4f13d24310aed981864569390f38c9bf8069355659114debc433475268b63cb648590aa2656ef7464ddc1b553c62f079e8ae433f0b9059cd3462a562016904d267994bb7e7d5cde5ef0fa7e39159eff9317e9e6a7165dc2e934d57cb72a3c58eb70dc28674c3b1277a7d0532dad0e9d0dadb345a1e3f939d1ce7fdc076552');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3216, 21106, 'Verapamil', 'Consumption of large quantities of grapefruit juice may be associated with significantly increased plasma concentrations of oral verapamil.  The mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grapefruit juice', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c458f516ec3300c43afc20bb418b0ee00432fb08ffdec53719444832d7b96bc22b79fd2a1e82f253e92d7aa364a73a98aba20535f193f83d4c585edd0d64e8d973ec4f13d24310aed981864569390f38c9bf8069355659114debc433475268b63cb648590aa2656ef7464ddc1b553c62f079e8ae433f0b9059cd3462a562016904d267994bb7e7d5cde5ef0fa7e39159eff9317e9e6a7165dc2e934d57cb72a3c58eb70dc28674c3b1277a7d0532dad0e9d0dadb345a1e3f939d1ce7fdc076552');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3217, 21107, 'Verapamil', 'Consumption of large quantities of grapefruit juice may be associated with significantly increased plasma concentrations of oral verapamil.  The mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grapefruit juice', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c458f516ec3300c43afc20bb418b0ee00432fb08ffdec53719444832d7b96bc22b79fd2a1e82f253e92d7aa364a73a98aba20535f193f83d4c585edd0d64e8d973ec4f13d24310aed981864569390f38c9bf8069355659114debc433475268b63cb648590aa2656ef7464ddc1b553c62f079e8ae433f0b9059cd3462a562016904d267994bb7e7d5cde5ef0fa7e39159eff9317e9e6a7165dc2e934d57cb72a3c58eb70dc28674c3b1277a7d0532dad0e9d0dadb345a1e3f939d1ce7fdc076552');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3218, 21108, 'Verapamil', 'Consumption of large quantities of grapefruit juice may be associated with significantly increased plasma concentrations of oral verapamil.  The mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grapefruit juice', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c458f516ec3300c43afc20bb418b0ee00432fb08ffdec53719444832d7b96bc22b79fd2a1e82f253e92d7aa364a73a98aba20535f193f83d4c585edd0d64e8d973ec4f13d24310aed981864569390f38c9bf8069355659114debc433475268b63cb648590aa2656ef7464ddc1b553c62f079e8ae433f0b9059cd3462a562016904d267994bb7e7d5cde5ef0fa7e39159eff9317e9e6a7165dc2e934d57cb72a3c58eb70dc28674c3b1277a7d0532dad0e9d0dadb345a1e3f939d1ce7fdc076552');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3219, 21109, 'Verapamil', 'Consumption of large quantities of grapefruit juice may be associated with significantly increased plasma concentrations of oral verapamil.  The mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grapefruit juice', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c458f516ec3300c43afc20bb418b0ee00432fb08ffdec53719444832d7b96bc22b79fd2a1e82f253e92d7aa364a73a98aba20535f193f83d4c585edd0d64e8d973ec4f13d24310aed981864569390f38c9bf8069355659114debc433475268b63cb648590aa2656ef7464ddc1b553c62f079e8ae433f0b9059cd3462a562016904d267994bb7e7d5cde5ef0fa7e39159eff9317e9e6a7165dc2e934d57cb72a3c58eb70dc28674c3b1277a7d0532dad0e9d0dadb345a1e3f939d1ce7fdc076552');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3220, 29139, 'Verapamil', 'Consumption of large quantities of grapefruit juice may be associated with significantly increased plasma concentrations of oral verapamil.  The mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grapefruit juice', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c458f516ec3300c43afc20bb418b0ee00432fb08ffdec53719444832d7b96bc22b79fd2a1e82f253e92d7aa364a73a98aba20535f193f83d4c585edd0d64e8d973ec4f13d24310aed981864569390f38c9bf8069355659114debc433475268b63cb648590aa2656ef7464ddc1b553c62f079e8ae433f0b9059cd3462a562016904d267994bb7e7d5cde5ef0fa7e39159eff9317e9e6a7165dc2e934d57cb72a3c58eb70dc28674c3b1277a7d0532dad0e9d0dadb345a1e3f939d1ce7fdc076552');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3221, 29141, 'Verapamil', 'Consumption of large quantities of grapefruit juice may be associated with significantly increased plasma concentrations of oral verapamil.  The mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grapefruit juice', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c458f516ec3300c43afc20bb418b0ee00432fb08ffdec53719444832d7b96bc22b79fd2a1e82f253e92d7aa364a73a98aba20535f193f83d4c585edd0d64e8d973ec4f13d24310aed981864569390f38c9bf8069355659114debc433475268b63cb648590aa2656ef7464ddc1b553c62f079e8ae433f0b9059cd3462a562016904d267994bb7e7d5cde5ef0fa7e39159eff9317e9e6a7165dc2e934d57cb72a3c58eb70dc28674c3b1277a7d0532dad0e9d0dadb345a1e3f939d1ce7fdc076552');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3222, 29182, 'Verapamil', 'Consumption of large quantities of grapefruit juice may be associated with significantly increased plasma concentrations of oral verapamil.  The mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grapefruit juice', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c458f516ec3300c43afc20bb418b0ee00432fb08ffdec53719444832d7b96bc22b79fd2a1e82f253e92d7aa364a73a98aba20535f193f83d4c585edd0d64e8d973ec4f13d24310aed981864569390f38c9bf8069355659114debc433475268b63cb648590aa2656ef7464ddc1b553c62f079e8ae433f0b9059cd3462a562016904d267994bb7e7d5cde5ef0fa7e39159eff9317e9e6a7165dc2e934d57cb72a3c58eb70dc28674c3b1277a7d0532dad0e9d0dadb345a1e3f939d1ce7fdc076552');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3223, 209, 'Valsartan', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3224, 2084, 'Valsartan', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3225, 3718, 'Valsartan', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c3d90eb6d043108845ba180d335910622a502d6b06b24afb10c5ec5577df09e2e3f79cc37035f385cb402568254d4184eade2daa51eb06b07e28b8bb693ab83ee906753e76a4b230648971813d0b80549914ea962def1c686c23307158f00d813e047cfa886e7b0706183ce49cfc013e0a5420b832569d60252a1056729d71acbb5a6179a929418acd5ea1299b8dfa12e06eae3583edf1fa1651d8560e3ffb0ae6f2be8623763eba37999b0773d01c1c46f765c1faee3dcd6ed4da3fdf95410aabaec735d271d5a9e2649307e721f3c817f2353044891485e2fa96cf68022478e3112d3bb61b3266dfc08aff888399ad82ac031e599b093e0f30fc2489eac', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3226, 3739, 'Valsartan', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3227, 3741, 'Valsartan', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3228, 11177, 'Valsartan', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3229, 11178, 'Valsartan', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c3d90eb6d043108845ba180d335910622a502d6b06b24afb10c5ec5577df09e2e3f79cc37035f385cb402568254d4184eade2daa51eb06b07e28b8bb693ab83ee906753e76a4b230648971813d0b80549914ea962def1c686c23307158f00d813e047cfa886e7b0706183ce49cfc013e0a5420b832569d60252a1056729d71acbb5a6179a929418acd5ea1299b8dfa12e06eae3583edf1fa1651d8560e3ffb0ae6f2be8623763eba37999b0773d01c1c46f765c1faee3dcd6ed4da3fdf95410aabaec735d271d5a9e2649307e721f3c817f2353044891485e2fa96cf68022478e3112d3bb61b3266dfc08aff888399ad82ac031e599b093e0f30fc2489eac', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3230, 11179, 'Valsartan', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3231, 11182, 'Valsartan', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c3d90eb6d043108845ba180d335910622a502d6b06b24afb10c5ec5577df09e2e3f79cc37035f385cb402568254d4184eade2daa51eb06b07e28b8bb693ab83ee906753e76a4b230648971813d0b80549914ea962def1c686c23307158f00d813e047cfa886e7b0706183ce49cfc013e0a5420b832569d60252a1056729d71acbb5a6179a929418acd5ea1299b8dfa12e06eae3583edf1fa1651d8560e3ffb0ae6f2be8623763eba37999b0773d01c1c46f765c1faee3dcd6ed4da3fdf95410aabaec735d271d5a9e2649307e721f3c817f2353044891485e2fa96cf68022478e3112d3bb61b3266dfc08aff888399ad82ac031e599b093e0f30fc2489eac', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3232, 12108, 'Valsartan', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3233, 15861, 'Valsartan', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3234, 20708, 'Valsartan', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3235, 21621, 'Valsartan', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3236, 21622, 'Valsartan', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3237, 21623, 'Valsartan', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3238, 21624, 'Valsartan', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c55504b72c33008bd0acb76c6f125b26e373d019148c454161a81d3e8f645b217ed8e81f7789f0f2c1daaf690c41235acb41b07c012e1faf975c160fc24c007155378a3f5b12e7e7cb1e4ee385d4029e2c0f8987a2d726cb11847aa8d547d3c17a7cc044865e1380e394892bcc0b66bc8048d32be06e71de895f8c636fe8a51d1e184ee770ae32169a5c0987387b8372e0fe0c2c6ee450ac81d8e347d2689a2ced480799e5780ab60dc9ca0d60ec60f5b9a265d8cdaa9a6933d8bf967e2a8637145a8d83cd09eb1c1135522bb84b48388b926bcdcb2846f6a0edfb07b3cddb30d26c6c8f62712b80bc74a8459dbdee8506f96440d9575fd05d6c1a145');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3239, 25198, 'Valsartan', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3240, 26550, 'Valsartan', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3241, 27309, 'Valsartan', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3242, 27310, 'Valsartan', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3243, 27907, 'Valsartan', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3244, 28938, 'Valsartan', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3245, 28939, 'Valsartan', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3246, 29031, 'Valsartan', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3247, 29032, 'Valsartan', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c55504b72c33008bd0acb76c6f125b26e373d019148c454161a81d3e8f645b217ed8e81f7789f0f2c1daaf690c41235acb41b07c012e1faf975c160fc24c007155378a3f5b12e7e7cb1e4ee385d4029e2c0f8987a2d726cb11847aa8d547d3c17a7cc044865e1380e394892bcc0b66bc8048d32be06e71de895f8c636fe8a51d1e184ee770ae32169a5c0987387b8372e0fe0c2c6ee450ac81d8e347d2689a2ced480799e5780ab60dc9ca0d60ec60f5b9a265d8cdaa9a6933d8bf967e2a8637145a8d83cd09eb1c1135522bb84b48388b926bcdcb2846f6a0edfb07b3cddb30d26c6c8f62712b80bc74a8459dbdee8506f96440d9575fd05d6c1a145');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3248, 31460, 'Valsartan', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3249, 209, 'Valsartan', 'Moderate-to-high dietary intake of potassium, especially salt substitutes, may increase the risk of hyperkalemia in some patients who are using angiotensin II receptor blockers (ARBs).  ARBs can promote hyperkalemia through inhibition of angiotensin II-induced aldosterone secretion.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c554f396ec3400cfcca940960f90f49e7224d7e40ad265e42abe582a410e8f7964a578301e6fcb1852ec9296daafaac5894297e407bca4ad81f86a544e8beddc0182c2aad1d086989d8e748cd3d19376c72b98a5382c84ab8c67a05d463d05769dc544e05c23662482a7b06feab419cd843fb13d29f6ac97e123c1e70168e34c7dcacacf4c0c7d7ef777cde810b51a463b86da7e5bd26abdb7eded15e75d654ebd792f7f449fbb2172e90b65824dd3a113c1f5cfafb0b35ae68bc');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3250, 2084, 'Valsartan', 'Moderate-to-high dietary intake of potassium, especially salt substitutes, may increase the risk of hyperkalemia in some patients who are using angiotensin II receptor blockers (ARBs).  ARBs can promote hyperkalemia through inhibition of angiotensin II-induced aldosterone secretion.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c554f396ec3400cfcca940960f90f49e7224d7e40ad265e42abe582a410e8f7964a578301e6fcb1852ec9296daafaac5894297e407bca4ad81f86a544e8beddc0182c2aad1d086989d8e748cd3d19376c72b98a5382c84ab8c67a05d463d05769dc544e05c23662482a7b06feab419cd843fb13d29f6ac97e123c1e70168e34c7dcacacf4c0c7d7ef777cde810b51a463b86da7e5bd26abdb7eded15e75d654ebd792f7f449fbb2172e90b65824dd3a113c1f5cfafb0b35ae68bc');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3251, 3718, 'Valsartan', 'Moderate-to-high dietary intake of potassium, especially salt substitutes, may increase the risk of hyperkalemia in some patients who are using angiotensin II receptor blockers (ARBs).  ARBs can promote hyperkalemia through inhibition of angiotensin II-induced aldosterone secretion.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c554f396ec3400cfcca940960f90f49e7224d7e40ad265e42abe582a410e8f7964a578301e6fcb1852ec9296daafaac5894297e407bca4ad81f86a544e8beddc0182c2aad1d086989d8e748cd3d19376c72b98a5382c84ab8c67a05d463d05769dc544e05c23662482a7b06feab419cd843fb13d29f6ac97e123c1e70168e34c7dcacacf4c0c7d7ef777cde810b51a463b86da7e5bd26abdb7eded15e75d654ebd792f7f449fbb2172e90b65824dd3a113c1f5cfafb0b35ae68bc');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3252, 3739, 'Valsartan', 'Moderate-to-high dietary intake of potassium, especially salt substitutes, may increase the risk of hyperkalemia in some patients who are using angiotensin II receptor blockers (ARBs).  ARBs can promote hyperkalemia through inhibition of angiotensin II-induced aldosterone secretion.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c554f396ec3400cfcca940960f90f49e7224d7e40ad265e42abe582a410e8f7964a578301e6fcb1852ec9296daafaac5894297e407bca4ad81f86a544e8beddc0182c2aad1d086989d8e748cd3d19376c72b98a5382c84ab8c67a05d463d05769dc544e05c23662482a7b06feab419cd843fb13d29f6ac97e123c1e70168e34c7dcacacf4c0c7d7ef777cde810b51a463b86da7e5bd26abdb7eded15e75d654ebd792f7f449fbb2172e90b65824dd3a113c1f5cfafb0b35ae68bc');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3253, 3741, 'Valsartan', 'Moderate-to-high dietary intake of potassium, especially salt substitutes, may increase the risk of hyperkalemia in some patients who are using angiotensin II receptor blockers (ARBs).  ARBs can promote hyperkalemia through inhibition of angiotensin II-induced aldosterone secretion.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c554f396ec3400cfcca940960f90f49e7224d7e40ad265e42abe582a410e8f7964a578301e6fcb1852ec9296daafaac5894297e407bca4ad81f86a544e8beddc0182c2aad1d086989d8e748cd3d19376c72b98a5382c84ab8c67a05d463d05769dc544e05c23662482a7b06feab419cd843fb13d29f6ac97e123c1e70168e34c7dcacacf4c0c7d7ef777cde810b51a463b86da7e5bd26abdb7eded15e75d654ebd792f7f449fbb2172e90b65824dd3a113c1f5cfafb0b35ae68bc');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3254, 11177, 'Valsartan', 'Moderate-to-high dietary intake of potassium, especially salt substitutes, may increase the risk of hyperkalemia in some patients who are using angiotensin II receptor blockers (ARBs).  ARBs can promote hyperkalemia through inhibition of angiotensin II-induced aldosterone secretion.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c554f396ec3400cfcca940960f90f49e7224d7e40ad265e42abe582a410e8f7964a578301e6fcb1852ec9296daafaac5894297e407bca4ad81f86a544e8beddc0182c2aad1d086989d8e748cd3d19376c72b98a5382c84ab8c67a05d463d05769dc544e05c23662482a7b06feab419cd843fb13d29f6ac97e123c1e70168e34c7dcacacf4c0c7d7ef777cde810b51a463b86da7e5bd26abdb7eded15e75d654ebd792f7f449fbb2172e90b65824dd3a113c1f5cfafb0b35ae68bc');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3255, 11178, 'Valsartan', 'Moderate-to-high dietary intake of potassium, especially salt substitutes, may increase the risk of hyperkalemia in some patients who are using angiotensin II receptor blockers (ARBs).  ARBs can promote hyperkalemia through inhibition of angiotensin II-induced aldosterone secretion.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c554f396ec3400cfcca940960f90f49e7224d7e40ad265e42abe582a410e8f7964a578301e6fcb1852ec9296daafaac5894297e407bca4ad81f86a544e8beddc0182c2aad1d086989d8e748cd3d19376c72b98a5382c84ab8c67a05d463d05769dc544e05c23662482a7b06feab419cd843fb13d29f6ac97e123c1e70168e34c7dcacacf4c0c7d7ef777cde810b51a463b86da7e5bd26abdb7eded15e75d654ebd792f7f449fbb2172e90b65824dd3a113c1f5cfafb0b35ae68bc');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3256, 11179, 'Valsartan', 'Moderate-to-high dietary intake of potassium, especially salt substitutes, may increase the risk of hyperkalemia in some patients who are using angiotensin II receptor blockers (ARBs).  ARBs can promote hyperkalemia through inhibition of angiotensin II-induced aldosterone secretion.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c554f396ec3400cfcca940960f90f49e7224d7e40ad265e42abe582a410e8f7964a578301e6fcb1852ec9296daafaac5894297e407bca4ad81f86a544e8beddc0182c2aad1d086989d8e748cd3d19376c72b98a5382c84ab8c67a05d463d05769dc544e05c23662482a7b06feab419cd843fb13d29f6ac97e123c1e70168e34c7dcacacf4c0c7d7ef777cde810b51a463b86da7e5bd26abdb7eded15e75d654ebd792f7f449fbb2172e90b65824dd3a113c1f5cfafb0b35ae68bc');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3257, 11182, 'Valsartan', 'Moderate-to-high dietary intake of potassium, especially salt substitutes, may increase the risk of hyperkalemia in some patients who are using angiotensin II receptor blockers (ARBs).  ARBs can promote hyperkalemia through inhibition of angiotensin II-induced aldosterone secretion.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c554f396ec3400cfcca940960f90f49e7224d7e40ad265e42abe582a410e8f7964a578301e6fcb1852ec9296daafaac5894297e407bca4ad81f86a544e8beddc0182c2aad1d086989d8e748cd3d19376c72b98a5382c84ab8c67a05d463d05769dc544e05c23662482a7b06feab419cd843fb13d29f6ac97e123c1e70168e34c7dcacacf4c0c7d7ef777cde810b51a463b86da7e5bd26abdb7eded15e75d654ebd792f7f449fbb2172e90b65824dd3a113c1f5cfafb0b35ae68bc');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3258, 12108, 'Valsartan', 'Moderate-to-high dietary intake of potassium, especially salt substitutes, may increase the risk of hyperkalemia in some patients who are using angiotensin II receptor blockers (ARBs).  ARBs can promote hyperkalemia through inhibition of angiotensin II-induced aldosterone secretion.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c554f396ec3400cfcca940960f90f49e7224d7e40ad265e42abe582a410e8f7964a578301e6fcb1852ec9296daafaac5894297e407bca4ad81f86a544e8beddc0182c2aad1d086989d8e748cd3d19376c72b98a5382c84ab8c67a05d463d05769dc544e05c23662482a7b06feab419cd843fb13d29f6ac97e123c1e70168e34c7dcacacf4c0c7d7ef777cde810b51a463b86da7e5bd26abdb7eded15e75d654ebd792f7f449fbb2172e90b65824dd3a113c1f5cfafb0b35ae68bc');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3259, 15861, 'Valsartan', 'Moderate-to-high dietary intake of potassium, especially salt substitutes, may increase the risk of hyperkalemia in some patients who are using angiotensin II receptor blockers (ARBs).  ARBs can promote hyperkalemia through inhibition of angiotensin II-induced aldosterone secretion.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c554f396ec3400cfcca940960f90f49e7224d7e40ad265e42abe582a410e8f7964a578301e6fcb1852ec9296daafaac5894297e407bca4ad81f86a544e8beddc0182c2aad1d086989d8e748cd3d19376c72b98a5382c84ab8c67a05d463d05769dc544e05c23662482a7b06feab419cd843fb13d29f6ac97e123c1e70168e34c7dcacacf4c0c7d7ef777cde810b51a463b86da7e5bd26abdb7eded15e75d654ebd792f7f449fbb2172e90b65824dd3a113c1f5cfafb0b35ae68bc');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3260, 20708, 'Valsartan', 'Moderate-to-high dietary intake of potassium, especially salt substitutes, may increase the risk of hyperkalemia in some patients who are using angiotensin II receptor blockers (ARBs).  ARBs can promote hyperkalemia through inhibition of angiotensin II-induced aldosterone secretion.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c554f396ec3400cfcca940960f90f49e7224d7e40ad265e42abe582a410e8f7964a578301e6fcb1852ec9296daafaac5894297e407bca4ad81f86a544e8beddc0182c2aad1d086989d8e748cd3d19376c72b98a5382c84ab8c67a05d463d05769dc544e05c23662482a7b06feab419cd843fb13d29f6ac97e123c1e70168e34c7dcacacf4c0c7d7ef777cde810b51a463b86da7e5bd26abdb7eded15e75d654ebd792f7f449fbb2172e90b65824dd3a113c1f5cfafb0b35ae68bc');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3261, 21621, 'Valsartan', 'Moderate-to-high dietary intake of potassium, especially salt substitutes, may increase the risk of hyperkalemia in some patients who are using angiotensin II receptor blockers (ARBs).  ARBs can promote hyperkalemia through inhibition of angiotensin II-induced aldosterone secretion.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c554f396ec3400cfcca940960f90f49e7224d7e40ad265e42abe582a410e8f7964a578301e6fcb1852ec9296daafaac5894297e407bca4ad81f86a544e8beddc0182c2aad1d086989d8e748cd3d19376c72b98a5382c84ab8c67a05d463d05769dc544e05c23662482a7b06feab419cd843fb13d29f6ac97e123c1e70168e34c7dcacacf4c0c7d7ef777cde810b51a463b86da7e5bd26abdb7eded15e75d654ebd792f7f449fbb2172e90b65824dd3a113c1f5cfafb0b35ae68bc');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3262, 21622, 'Valsartan', 'Moderate-to-high dietary intake of potassium, especially salt substitutes, may increase the risk of hyperkalemia in some patients who are using angiotensin II receptor blockers (ARBs).  ARBs can promote hyperkalemia through inhibition of angiotensin II-induced aldosterone secretion.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'789c6591516ec3300c43afa203a4bdc7fe7a05d5661a218e155872b6dc7e72b7a140f76b50e4237d63175437b2457bc9d4902007280b9cdb49497b3514a90fe29ae90ee27c8821932b5575ea06dad5d94cfa76495a9da50eb97171b27e3717ef0e236da407dac5175c86ada3bd2e43b9ef05db93e5533c683cc2abf5e2c32d8e24e4cb699284eb95e863fe1fc10d03288fcbd45b0bb7724e51ead10b37dab48a6b1b7e1ad76891fb222838508cc4c608ba054a468ea0dbdb445c4cdf863060a50d59121762f7908b569279709f84af1d2d3c12c8ce6d77dd6c002c673caf1cad85a3465a88a33b78ad309b48da1ff7026e7e07fb348acdddc27ca2b14bf9ed123191e22dac02368e63ec19cf7ffb89021f326c49ea535cf0b0eb3796edbfbf', NULL, X'789c554f396ec3400cfcca940960f90f49e7224d7e40ad265e42abe582a410e8f7964a578301e6fcb1852ec9296daafaac5894297e407bca4ad81f86a544e8beddc0182c2aad1d086989d8e748cd3d19376c72b98a5382c84ab8c67a05d463d05769dc544e05c23662482a7b06feab419cd843fb13d29f6ac97e123c1e70168e34c7dcacacf4c0c7d7ef777cde810b51a463b86da7e5bd26abdb7eded15e75d654ebd792f7f449fbb2172e90b65824dd3a113c1f5cfafb0b35ae68bc');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3263, 21623, 'Valsartan', 'Moderate-to-high dietary intake of potassium, especially salt substitutes, may increase the risk of hyperkalemia in some patients who are using angiotensin II receptor blockers (ARBs).  ARBs can promote hyperkalemia through inhibition of angiotensin II-induced aldosterone secretion.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c554f396ec3400cfcca940960f90f49e7224d7e40ad265e42abe582a410e8f7964a578301e6fcb1852ec9296daafaac5894297e407bca4ad81f86a544e8beddc0182c2aad1d086989d8e748cd3d19376c72b98a5382c84ab8c67a05d463d05769dc544e05c23662482a7b06feab419cd843fb13d29f6ac97e123c1e70168e34c7dcacacf4c0c7d7ef777cde810b51a463b86da7e5bd26abdb7eded15e75d654ebd792f7f449fbb2172e90b65824dd3a113c1f5cfafb0b35ae68bc');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3264, 21624, 'Valsartan', 'Moderate-to-high dietary intake of potassium, especially salt substitutes, may increase the risk of hyperkalemia in some patients who are using angiotensin II receptor blockers (ARBs).  ARBs can promote hyperkalemia through inhibition of angiotensin II-induced aldosterone secretion.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c554f396ec3400cfcca940960f90f49e7224d7e40ad265e42abe582a410e8f7964a578301e6fcb1852ec9296daafaac5894297e407bca4ad81f86a544e8beddc0182c2aad1d086989d8e748cd3d19376c72b98a5382c84ab8c67a05d463d05769dc544e05c23662482a7b06feab419cd843fb13d29f6ac97e123c1e70168e34c7dcacacf4c0c7d7ef777cde810b51a463b86da7e5bd26abdb7eded15e75d654ebd792f7f449fbb2172e90b65824dd3a113c1f5cfafb0b35ae68bc');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3265, 25198, 'Valsartan', 'Moderate-to-high dietary intake of potassium, especially salt substitutes, may increase the risk of hyperkalemia in some patients who are using angiotensin II receptor blockers (ARBs).  ARBs can promote hyperkalemia through inhibition of angiotensin II-induced aldosterone secretion.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c554f396ec3400cfcca940960f90f49e7224d7e40ad265e42abe582a410e8f7964a578301e6fcb1852ec9296daafaac5894297e407bca4ad81f86a544e8beddc0182c2aad1d086989d8e748cd3d19376c72b98a5382c84ab8c67a05d463d05769dc544e05c23662482a7b06feab419cd843fb13d29f6ac97e123c1e70168e34c7dcacacf4c0c7d7ef777cde810b51a463b86da7e5bd26abdb7eded15e75d654ebd792f7f449fbb2172e90b65824dd3a113c1f5cfafb0b35ae68bc');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3266, 26550, 'Valsartan', 'Moderate-to-high dietary intake of potassium, especially salt substitutes, may increase the risk of hyperkalemia in some patients who are using angiotensin II receptor blockers (ARBs).  ARBs can promote hyperkalemia through inhibition of angiotensin II-induced aldosterone secretion.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c554f396ec3400cfcca940960f90f49e7224d7e40ad265e42abe582a410e8f7964a578301e6fcb1852ec9296daafaac5894297e407bca4ad81f86a544e8beddc0182c2aad1d086989d8e748cd3d19376c72b98a5382c84ab8c67a05d463d05769dc544e05c23662482a7b06feab419cd843fb13d29f6ac97e123c1e70168e34c7dcacacf4c0c7d7ef777cde810b51a463b86da7e5bd26abdb7eded15e75d654ebd792f7f449fbb2172e90b65824dd3a113c1f5cfafb0b35ae68bc');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3267, 27309, 'Valsartan', 'Moderate-to-high dietary intake of potassium, especially salt substitutes, may increase the risk of hyperkalemia in some patients who are using angiotensin II receptor blockers (ARBs).  ARBs can promote hyperkalemia through inhibition of angiotensin II-induced aldosterone secretion.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'789c6591516ec3300c43afa203a4bdc7fe7a05d5661a218e155872b6dc7e72b7a140f76b50e4237d63175437b2457bc9d4902007280b9cdb49497b3514a90fe29ae90ee27c8821932b5575ea06dad5d94cfa76495a9da50eb97171b27e3717ef0e236da407dac5175c86ada3bd2e43b9ef05db93e5533c683cc2abf5e2c32d8e24e4cb699284eb95e863fe1fc10d03288fcbd45b0bb7724e51ead10b37dab48a6b1b7e1ad76891fb222838508cc4c608ba054a468ea0dbdb445c4cdf863060a50d59121762f7908b569279709f84af1d2d3c12c8ce6d77dd6c002c673caf1cad85a3465a88a33b78ad309b48da1ff7026e7e07fb348acdddc27ca2b14bf9ed123191e22dac02368e63ec19cf7ffb89021f326c49ea535cf0b0eb3796edbfbf', NULL, X'789c554f396ec3400cfcca940960f90f49e7224d7e40ad265e42abe582a410e8f7964a578301e6fcb1852ec9296daafaac5894297e407bca4ad81f86a544e8beddc0182c2aad1d086989d8e748cd3d19376c72b98a5382c84ab8c67a05d463d05769dc544e05c23662482a7b06feab419cd843fb13d29f6ac97e123c1e70168e34c7dcacacf4c0c7d7ef777cde810b51a463b86da7e5bd26abdb7eded15e75d654ebd792f7f449fbb2172e90b65824dd3a113c1f5cfafb0b35ae68bc');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3268, 27310, 'Valsartan', 'Moderate-to-high dietary intake of potassium, especially salt substitutes, may increase the risk of hyperkalemia in some patients who are using angiotensin II receptor blockers (ARBs).  ARBs can promote hyperkalemia through inhibition of angiotensin II-induced aldosterone secretion.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c554f396ec3400cfcca940960f90f49e7224d7e40ad265e42abe582a410e8f7964a578301e6fcb1852ec9296daafaac5894297e407bca4ad81f86a544e8beddc0182c2aad1d086989d8e748cd3d19376c72b98a5382c84ab8c67a05d463d05769dc544e05c23662482a7b06feab419cd843fb13d29f6ac97e123c1e70168e34c7dcacacf4c0c7d7ef777cde810b51a463b86da7e5bd26abdb7eded15e75d654ebd792f7f449fbb2172e90b65824dd3a113c1f5cfafb0b35ae68bc');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3269, 27907, 'Valsartan', 'Moderate-to-high dietary intake of potassium, especially salt substitutes, may increase the risk of hyperkalemia in some patients who are using angiotensin II receptor blockers (ARBs).  ARBs can promote hyperkalemia through inhibition of angiotensin II-induced aldosterone secretion.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c554f396ec3400cfcca940960f90f49e7224d7e40ad265e42abe582a410e8f7964a578301e6fcb1852ec9296daafaac5894297e407bca4ad81f86a544e8beddc0182c2aad1d086989d8e748cd3d19376c72b98a5382c84ab8c67a05d463d05769dc544e05c23662482a7b06feab419cd843fb13d29f6ac97e123c1e70168e34c7dcacacf4c0c7d7ef777cde810b51a463b86da7e5bd26abdb7eded15e75d654ebd792f7f449fbb2172e90b65824dd3a113c1f5cfafb0b35ae68bc');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3270, 28938, 'Valsartan', 'Moderate-to-high dietary intake of potassium, especially salt substitutes, may increase the risk of hyperkalemia in some patients who are using angiotensin II receptor blockers (ARBs).  ARBs can promote hyperkalemia through inhibition of angiotensin II-induced aldosterone secretion.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c554f396ec3400cfcca940960f90f49e7224d7e40ad265e42abe582a410e8f7964a578301e6fcb1852ec9296daafaac5894297e407bca4ad81f86a544e8beddc0182c2aad1d086989d8e748cd3d19376c72b98a5382c84ab8c67a05d463d05769dc544e05c23662482a7b06feab419cd843fb13d29f6ac97e123c1e70168e34c7dcacacf4c0c7d7ef777cde810b51a463b86da7e5bd26abdb7eded15e75d654ebd792f7f449fbb2172e90b65824dd3a113c1f5cfafb0b35ae68bc');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3271, 28939, 'Valsartan', 'Moderate-to-high dietary intake of potassium, especially salt substitutes, may increase the risk of hyperkalemia in some patients who are using angiotensin II receptor blockers (ARBs).  ARBs can promote hyperkalemia through inhibition of angiotensin II-induced aldosterone secretion.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c554f396ec3400cfcca940960f90f49e7224d7e40ad265e42abe582a410e8f7964a578301e6fcb1852ec9296daafaac5894297e407bca4ad81f86a544e8beddc0182c2aad1d086989d8e748cd3d19376c72b98a5382c84ab8c67a05d463d05769dc544e05c23662482a7b06feab419cd843fb13d29f6ac97e123c1e70168e34c7dcacacf4c0c7d7ef777cde810b51a463b86da7e5bd26abdb7eded15e75d654ebd792f7f449fbb2172e90b65824dd3a113c1f5cfafb0b35ae68bc');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3272, 29031, 'Valsartan', 'Moderate-to-high dietary intake of potassium, especially salt substitutes, may increase the risk of hyperkalemia in some patients who are using angiotensin II receptor blockers (ARBs).  ARBs can promote hyperkalemia through inhibition of angiotensin II-induced aldosterone secretion.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c554f396ec3400cfcca940960f90f49e7224d7e40ad265e42abe582a410e8f7964a578301e6fcb1852ec9296daafaac5894297e407bca4ad81f86a544e8beddc0182c2aad1d086989d8e748cd3d19376c72b98a5382c84ab8c67a05d463d05769dc544e05c23662482a7b06feab419cd843fb13d29f6ac97e123c1e70168e34c7dcacacf4c0c7d7ef777cde810b51a463b86da7e5bd26abdb7eded15e75d654ebd792f7f449fbb2172e90b65824dd3a113c1f5cfafb0b35ae68bc');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3273, 29032, 'Valsartan', 'Moderate-to-high dietary intake of potassium, especially salt substitutes, may increase the risk of hyperkalemia in some patients who are using angiotensin II receptor blockers (ARBs).  ARBs can promote hyperkalemia through inhibition of angiotensin II-induced aldosterone secretion.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c554f396ec3400cfcca940960f90f49e7224d7e40ad265e42abe582a410e8f7964a578301e6fcb1852ec9296daafaac5894297e407bca4ad81f86a544e8beddc0182c2aad1d086989d8e748cd3d19376c72b98a5382c84ab8c67a05d463d05769dc544e05c23662482a7b06feab419cd843fb13d29f6ac97e123c1e70168e34c7dcacacf4c0c7d7ef777cde810b51a463b86da7e5bd26abdb7eded15e75d654ebd792f7f449fbb2172e90b65824dd3a113c1f5cfafb0b35ae68bc');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3274, 31460, 'Valsartan', 'Moderate-to-high dietary intake of potassium, especially salt substitutes, may increase the risk of hyperkalemia in some patients who are using angiotensin II receptor blockers (ARBs).  ARBs can promote hyperkalemia through inhibition of angiotensin II-induced aldosterone secretion.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c554f396ec3400cfcca940960f90f49e7224d7e40ad265e42abe582a410e8f7964a578301e6fcb1852ec9296daafaac5894297e407bca4ad81f86a544e8beddc0182c2aad1d086989d8e748cd3d19376c72b98a5382c84ab8c67a05d463d05769dc544e05c23662482a7b06feab419cd843fb13d29f6ac97e123c1e70168e34c7dcacacf4c0c7d7ef777cde810b51a463b86da7e5bd26abdb7eded15e75d654ebd792f7f449fbb2172e90b65824dd3a113c1f5cfafb0b35ae68bc');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3275, 2471, 'Varenicline', 'Varenicline may enhance the effects of alcohol as well as alter the way an individual reacts to alcohol.  During postmarketing use, some patients have reported experiencing increased intoxicating effects of alcohol while taking varenicline.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c6d8fcb0dc3300c4357e10045a7e80cbd0b0e530b7164c3563eddbe7680a2979e04897c84f8944ad390d48855dea045b140782438cf0cde9067480a39e604693898ae29c9592fdfd13931a84dbaebb44942a50cd0f317bc038fadaabd5072f355ea421fdbd67843cb2b51c495d6a1283b7b40c9d539816761ed42186eb5d0935b3fab793e35c815f2e7cf236aea256419fafeeb78ff00a56c5950');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3276, 16219, 'Varenicline', 'Varenicline may enhance the effects of alcohol as well as alter the way an individual reacts to alcohol.  During postmarketing use, some patients have reported experiencing increased intoxicating effects of alcohol while taking varenicline.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c6d8fcb0dc3300c4357e10045a7e80cbd0b0e530b7164c3563eddbe7680a2979e04897c84f8944ad390d48855dea045b140782438cf0cde9067480a39e604693898ae29c9592fdfd13931a84dbaebb44942a50cd0f317bc038fadaabd5072f355ea421fdbd67843cb2b51c495d6a1283b7b40c9d539816761ed42186eb5d0935b3fab793e35c815f2e7cf236aea256419fafeeb78ff00a56c5950');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3277, 7255, 'Vardenafil', 'Additive hypotensive effects may occur when phosphodiesterase-5 (PDE5) inhibitors are used with alcohol, as both are mild systemic vasodilators.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458dc19102310c04539900b6f89101f72705618bb5ea6c69cb92b982e8b1791c4fa9a6bbaf14c21a8ea05fd11dd7cbcf19a2456e12d61d5e6cd40c7a986424531f6dcd2af59d41cdc662ed0eaac98ad50d7f455241a3e7b4a4cee48c288cc36266842aeed6613d8a79cc7682cbae0ed20c7fb623acf922ebc8abf3ef104561ea814ec11b327fffd3a39ff1ad9a651c9ddd475f2379bd44e7b57df493cf940a9fde815a5aaa', NULL, X'789c158c410ac3300c04bfb2c716dadef280427bef17145b4102db0a9693e0dfd73e2c2c3becbc63d4a62743fa6e8d8bcfcedbc6a1393275580847c5255cb08bf94854f6c6959c9f0b6ebfcf77b9438be8aacdaa832ae3708eb8b4092805134b0f9063b5390c9c3545781f96ac0127f970269aefd71f1b333510');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3278, 7519, 'Vardenafil', 'Additive hypotensive effects may occur when phosphodiesterase-5 (PDE5) inhibitors are used with alcohol, as both are mild systemic vasodilators.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458dc19102310c04539900b6f89101f72705618bb5ea6c69cb92b982e8b1791c4fa9a6bbaf14c21a8ea05fd11dd7cbcf19a2456e12d61d5e6cd40c7a986424531f6dcd2af59d41cdc662ed0eaac98ad50d7f455241a3e7b4a4cee48c288cc36266842aeed6613d8a79cc7682cbae0ed20c7fb623acf922ebc8abf3ef104561ea814ec11b327fffd3a39ff1ad9a651c9ddd475f2379bd44e7b57df493cf940a9fde815a5aaa', NULL, X'789c158c410ac3300c04bfb2c716dadef280427bef17145b4102db0a9693e0dfd73e2c2c3becbc63d4a62743fa6e8d8bcfcedbc6a1393275580847c5255cb08bf94854f6c6959c9f0b6ebfcf77b9438be8aacdaa832ae3708eb8b4092805134b0f9063b5390c9c3545781f96ac0127f970269aefd71f1b333510');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3279, 10684, 'Vardenafil', 'Additive hypotensive effects may occur when phosphodiesterase-5 (PDE5) inhibitors are used with alcohol, as both are mild systemic vasodilators.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458dc19102310c04539900b6f89101f72705618bb5ea6c69cb92b982e8b1791c4fa9a6bbaf14c21a8ea05fd11dd7cbcf19a2456e12d61d5e6cd40c7a986424531f6dcd2af59d41cdc662ed0eaac98ad50d7f455241a3e7b4a4cee48c288cc36266842aeed6613d8a79cc7682cbae0ed20c7fb623acf922ebc8abf3ef104561ea814ec11b327fffd3a39ff1ad9a651c9ddd475f2379bd44e7b57df493cf940a9fde815a5aaa', NULL, X'789c158c410ac3300c04bfb2c716dadef280427bef17145b4102db0a9693e0dfd73e2c2c3becbc63d4a62743fa6e8d8bcfcedbc6a1393275580847c5255cb08bf94854f6c6959c9f0b6ebfcf77b9438be8aacdaa832ae3708eb8b4092805134b0f9063b5390c9c3545781f96ac0127f970269aefd71f1b333510');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3280, 18514, 'Vardenafil', 'Additive hypotensive effects may occur when phosphodiesterase-5 (PDE5) inhibitors are used with alcohol, as both are mild systemic vasodilators.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458dc19102310c04539900b6f89101f72705618bb5ea6c69cb92b982e8b1791c4fa9a6bbaf14c21a8ea05fd11dd7cbcf19a2456e12d61d5e6cd40c7a986424531f6dcd2af59d41cdc662ed0eaac98ad50d7f455241a3e7b4a4cee48c288cc36266842aeed6613d8a79cc7682cbae0ed20c7fb623acf922ebc8abf3ef104561ea814ec11b327fffd3a39ff1ad9a651c9ddd475f2379bd44e7b57df493cf940a9fde815a5aaa', NULL, X'789c158c410ac3300c04bfb2c716dadef280427bef17145b4102db0a9693e0dfd73e2c2c3becbc63d4a62743fa6e8d8bcfcedbc6a1393275580847c5255cb08bf94854f6c6959c9f0b6ebfcf77b9438be8aacdaa832ae3708eb8b4092805134b0f9063b5390c9c3545781f96ac0127f970269aefd71f1b333510');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3281, 25111, 'Vardenafil', 'Additive hypotensive effects may occur when phosphodiesterase-5 (PDE5) inhibitors are used with alcohol, as both are mild systemic vasodilators.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458dc19102310c04539900b6f89101f72705618bb5ea6c69cb92b982e8b1791c4fa9a6bbaf14c21a8ea05fd11dd7cbcf19a2456e12d61d5e6cd40c7a986424531f6dcd2af59d41cdc662ed0eaac98ad50d7f455241a3e7b4a4cee48c288cc36266842aeed6613d8a79cc7682cbae0ed20c7fb623acf922ebc8abf3ef104561ea814ec11b327fffd3a39ff1ad9a651c9ddd475f2379bd44e7b57df493cf940a9fde815a5aaa', NULL, X'789c158c410ac3300c04bfb2c716dadef280427bef17145b4102db0a9693e0dfd73e2c2c3becbc63d4a62743fa6e8d8bcfcedbc6a1393275580847c5255cb08bf94854f6c6959c9f0b6ebfcf77b9438be8aacdaa832ae3708eb8b4092805134b0f9063b5390c9c3545781f96ac0127f970269aefd71f1b333510');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3282, 25112, 'Vardenafil', 'Additive hypotensive effects may occur when phosphodiesterase-5 (PDE5) inhibitors are used with alcohol, as both are mild systemic vasodilators.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458dc19102310c04539900b6f89101f72705618bb5ea6c69cb92b982e8b1791c4fa9a6bbaf14c21a8ea05fd11dd7cbcf19a2456e12d61d5e6cd40c7a986424531f6dcd2af59d41cdc662ed0eaac98ad50d7f455241a3e7b4a4cee48c288cc36266842aeed6613d8a79cc7682cbae0ed20c7fb623acf922ebc8abf3ef104561ea814ec11b327fffd3a39ff1ad9a651c9ddd475f2379bd44e7b57df493cf940a9fde815a5aaa', NULL, X'789c158c410ac3300c04bfb2c716dadef280427bef17145b4102db0a9693e0dfd73e2c2c3becbc63d4a62743fa6e8d8bcfcedbc6a1393275580847c5255cb08bf94854f6c6959c9f0b6ebfcf77b9438be8aacdaa832ae3708eb8b4092805134b0f9063b5390c9c3545781f96ac0127f970269aefd71f1b333510');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3283, 25113, 'Vardenafil', 'Additive hypotensive effects may occur when phosphodiesterase-5 (PDE5) inhibitors are used with alcohol, as both are mild systemic vasodilators.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458dc19102310c04539900b6f89101f72705618bb5ea6c69cb92b982e8b1791c4fa9a6bbaf14c21a8ea05fd11dd7cbcf19a2456e12d61d5e6cd40c7a986424531f6dcd2af59d41cdc662ed0eaac98ad50d7f455241a3e7b4a4cee48c288cc36266842aeed6613d8a79cc7682cbae0ed20c7fb623acf922ebc8abf3ef104561ea814ec11b327fffd3a39ff1ad9a651c9ddd475f2379bd44e7b57df493cf940a9fde815a5aaa', NULL, X'789c158c410ac3300c04bfb2c716dadef280427bef17145b4102db0a9693e0dfd73e2c2c3becbc63d4a62743fa6e8d8bcfcedbc6a1393275580847c5255cb08bf94854f6c6959c9f0b6ebfcf77b9438be8aacdaa832ae3708eb8b4092805134b0f9063b5390c9c3545781f96ac0127f970269aefd71f1b333510');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3284, 25114, 'Vardenafil', 'Additive hypotensive effects may occur when phosphodiesterase-5 (PDE5) inhibitors are used with alcohol, as both are mild systemic vasodilators.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458dc19102310c04539900b6f89101f72705618bb5ea6c69cb92b982e8b1791c4fa9a6bbaf14c21a8ea05fd11dd7cbcf19a2456e12d61d5e6cd40c7a986424531f6dcd2af59d41cdc662ed0eaac98ad50d7f455241a3e7b4a4cee48c288cc36266842aeed6613d8a79cc7682cbae0ed20c7fb623acf922ebc8abf3ef104561ea814ec11b327fffd3a39ff1ad9a651c9ddd475f2379bd44e7b57df493cf940a9fde815a5aaa', NULL, X'789c158c410ac3300c04bfb2c716dadef280427bef17145b4102db0a9693e0dfd73e2c2c3becbc63d4a62743fa6e8d8bcfcedbc6a1393275580847c5255cb08bf94854f6c6959c9f0b6ebfcf77b9438be8aacdaa832ae3708eb8b4092805134b0f9063b5390c9c3545781f96ac0127f970269aefd71f1b333510');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3285, 25115, 'Vardenafil', 'Additive hypotensive effects may occur when phosphodiesterase-5 (PDE5) inhibitors are used with alcohol, as both are mild systemic vasodilators.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458dc19102310c04539900b6f89101f72705618bb5ea6c69cb92b982e8b1791c4fa9a6bbaf14c21a8ea05fd11dd7cbcf19a2456e12d61d5e6cd40c7a986424531f6dcd2af59d41cdc662ed0eaac98ad50d7f455241a3e7b4a4cee48c288cc36266842aeed6613d8a79cc7682cbae0ed20c7fb623acf922ebc8abf3ef104561ea814ec11b327fffd3a39ff1ad9a651c9ddd475f2379bd44e7b57df493cf940a9fde815a5aaa', NULL, X'789c158c410ac3300c04bfb2c716dadef280427bef17145b4102db0a9693e0dfd73e2c2c3becbc63d4a62743fa6e8d8bcfcedbc6a1393275580847c5255cb08bf94854f6c6959c9f0b6ebfcf77b9438be8aacdaa832ae3708eb8b4092805134b0f9063b5390c9c3545781f96ac0127f970269aefd71f1b333510');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3286, 25778, 'Vardenafil', 'Additive hypotensive effects may occur when phosphodiesterase-5 (PDE5) inhibitors are used with alcohol, as both are mild systemic vasodilators.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458dc19102310c04539900b6f89101f72705618bb5ea6c69cb92b982e8b1791c4fa9a6bbaf14c21a8ea05fd11dd7cbcf19a2456e12d61d5e6cd40c7a986424531f6dcd2af59d41cdc662ed0eaac98ad50d7f455241a3e7b4a4cee48c288cc36266842aeed6613d8a79cc7682cbae0ed20c7fb623acf922ebc8abf3ef104561ea814ec11b327fffd3a39ff1ad9a651c9ddd475f2379bd44e7b57df493cf940a9fde815a5aaa', NULL, X'789c158c410ac3300c04bfb2c716dadef280427bef17145b4102db0a9693e0dfd73e2c2c3becbc63d4a62743fa6e8d8bcfcedbc6a1393275580847c5255cb08bf94854f6c6959c9f0b6ebfcf77b9438be8aacdaa832ae3708eb8b4092805134b0f9063b5390c9c3545781f96ac0127f970269aefd71f1b333510');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3287, 26260, 'Vardenafil', 'Additive hypotensive effects may occur when phosphodiesterase-5 (PDE5) inhibitors are used with alcohol, as both are mild systemic vasodilators.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458dc19102310c04539900b6f89101f72705618bb5ea6c69cb92b982e8b1791c4fa9a6bbaf14c21a8ea05fd11dd7cbcf19a2456e12d61d5e6cd40c7a986424531f6dcd2af59d41cdc662ed0eaac98ad50d7f455241a3e7b4a4cee48c288cc36266842aeed6613d8a79cc7682cbae0ed20c7fb623acf922ebc8abf3ef104561ea814ec11b327fffd3a39ff1ad9a651c9ddd475f2379bd44e7b57df493cf940a9fde815a5aaa', NULL, X'789c158c410ac3300c04bfb2c716dadef280427bef17145b4102db0a9693e0dfd73e2c2c3becbc63d4a62743fa6e8d8bcfcedbc6a1393275580847c5255cb08bf94854f6c6959c9f0b6ebfcf77b9438be8aacdaa832ae3708eb8b4092805134b0f9063b5390c9c3545781f96ac0127f970269aefd71f1b333510');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3288, 26261, 'Vardenafil', 'Additive hypotensive effects may occur when phosphodiesterase-5 (PDE5) inhibitors are used with alcohol, as both are mild systemic vasodilators.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458dc19102310c04539900b6f89101f72705618bb5ea6c69cb92b982e8b1791c4fa9a6bbaf14c21a8ea05fd11dd7cbcf19a2456e12d61d5e6cd40c7a986424531f6dcd2af59d41cdc662ed0eaac98ad50d7f455241a3e7b4a4cee48c288cc36266842aeed6613d8a79cc7682cbae0ed20c7fb623acf922ebc8abf3ef104561ea814ec11b327fffd3a39ff1ad9a651c9ddd475f2379bd44e7b57df493cf940a9fde815a5aaa', NULL, X'789c158c410ac3300c04bfb2c716dadef280427bef17145b4102db0a9693e0dfd73e2c2c3becbc63d4a62743fa6e8d8bcfcedbc6a1393275580847c5255cb08bf94854f6c6959c9f0b6ebfcf77b9438be8aacdaa832ae3708eb8b4092805134b0f9063b5390c9c3545781f96ac0127f970269aefd71f1b333510');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3289, 26353, 'Vardenafil', 'Additive hypotensive effects may occur when phosphodiesterase-5 (PDE5) inhibitors are used with alcohol, as both are mild systemic vasodilators.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458dc19102310c04539900b6f89101f72705618bb5ea6c69cb92b982e8b1791c4fa9a6bbaf14c21a8ea05fd11dd7cbcf19a2456e12d61d5e6cd40c7a986424531f6dcd2af59d41cdc662ed0eaac98ad50d7f455241a3e7b4a4cee48c288cc36266842aeed6613d8a79cc7682cbae0ed20c7fb623acf922ebc8abf3ef104561ea814ec11b327fffd3a39ff1ad9a651c9ddd475f2379bd44e7b57df493cf940a9fde815a5aaa', NULL, X'789c158c410ac3300c04bfb2c716dadef280427bef17145b4102db0a9693e0dfd73e2c2c3becbc63d4a62743fa6e8d8bcfcedbc6a1393275580847c5255cb08bf94854f6c6959c9f0b6ebfcf77b9438be8aacdaa832ae3708eb8b4092805134b0f9063b5390c9c3545781f96ac0127f970269aefd71f1b333510');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3290, 28605, 'Vardenafil', 'Additive hypotensive effects may occur when phosphodiesterase-5 (PDE5) inhibitors are used with alcohol, as both are mild systemic vasodilators.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458dc19102310c04539900b6f89101f72705618bb5ea6c69cb92b982e8b1791c4fa9a6bbaf14c21a8ea05fd11dd7cbcf19a2456e12d61d5e6cd40c7a986424531f6dcd2af59d41cdc662ed0eaac98ad50d7f455241a3e7b4a4cee48c288cc36266842aeed6613d8a79cc7682cbae0ed20c7fb623acf922ebc8abf3ef104561ea814ec11b327fffd3a39ff1ad9a651c9ddd475f2379bd44e7b57df493cf940a9fde815a5aaa', NULL, X'789c158c410ac3300c04bfb2c716dadef280427bef17145b4102db0a9693e0dfd73e2c2c3becbc63d4a62743fa6e8d8bcfcedbc6a1393275580847c5255cb08bf94854f6c6959c9f0b6ebfcf77b9438be8aacdaa832ae3708eb8b4092805134b0f9063b5390c9c3545781f96ac0127f970269aefd71f1b333510');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3291, 28981, 'Vardenafil', 'Additive hypotensive effects may occur when phosphodiesterase-5 (PDE5) inhibitors are used with alcohol, as both are mild systemic vasodilators.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458dc19102310c04539900b6f89101f72705618bb5ea6c69cb92b982e8b1791c4fa9a6bbaf14c21a8ea05fd11dd7cbcf19a2456e12d61d5e6cd40c7a986424531f6dcd2af59d41cdc662ed0eaac98ad50d7f455241a3e7b4a4cee48c288cc36266842aeed6613d8a79cc7682cbae0ed20c7fb623acf922ebc8abf3ef104561ea814ec11b327fffd3a39ff1ad9a651c9ddd475f2379bd44e7b57df493cf940a9fde815a5aaa', NULL, X'789c158c410ac3300c04bfb2c716dadef280427bef17145b4102db0a9693e0dfd73e2c2c3becbc63d4a62743fa6e8d8bcfcedbc6a1393275580847c5255cb08bf94854f6c6959c9f0b6ebfcf77b9438be8aacdaa832ae3708eb8b4092805134b0f9063b5390c9c3545781f96ac0127f970269aefd71f1b333510');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3292, 28982, 'Vardenafil', 'Additive hypotensive effects may occur when phosphodiesterase-5 (PDE5) inhibitors are used with alcohol, as both are mild systemic vasodilators.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458dc19102310c04539900b6f89101f72705618bb5ea6c69cb92b982e8b1791c4fa9a6bbaf14c21a8ea05fd11dd7cbcf19a2456e12d61d5e6cd40c7a986424531f6dcd2af59d41cdc662ed0eaac98ad50d7f455241a3e7b4a4cee48c288cc36266842aeed6613d8a79cc7682cbae0ed20c7fb623acf922ebc8abf3ef104561ea814ec11b327fffd3a39ff1ad9a651c9ddd475f2379bd44e7b57df493cf940a9fde815a5aaa', NULL, X'789c158c410ac3300c04bfb2c716dadef280427bef17145b4102db0a9693e0dfd73e2c2c3becbc63d4a62743fa6e8d8bcfcedbc6a1393275580847c5255cb08bf94854f6c6959c9f0b6ebfcf77b9438be8aacdaa832ae3708eb8b4092805134b0f9063b5390c9c3545781f96ac0127f970269aefd71f1b333510');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3293, 28983, 'Vardenafil', 'Additive hypotensive effects may occur when phosphodiesterase-5 (PDE5) inhibitors are used with alcohol, as both are mild systemic vasodilators.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458dc19102310c04539900b6f89101f72705618bb5ea6c69cb92b982e8b1791c4fa9a6bbaf14c21a8ea05fd11dd7cbcf19a2456e12d61d5e6cd40c7a986424531f6dcd2af59d41cdc662ed0eaac98ad50d7f455241a3e7b4a4cee48c288cc36266842aeed6613d8a79cc7682cbae0ed20c7fb623acf922ebc8abf3ef104561ea814ec11b327fffd3a39ff1ad9a651c9ddd475f2379bd44e7b57df493cf940a9fde815a5aaa', NULL, X'789c158c410ac3300c04bfb2c716dadef280427bef17145b4102db0a9693e0dfd73e2c2c3becbc63d4a62743fa6e8d8bcfcedbc6a1393275580847c5255cb08bf94854f6c6959c9f0b6ebfcf77b9438be8aacdaa832ae3708eb8b4092805134b0f9063b5390c9c3545781f96ac0127f970269aefd71f1b333510');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3294, 28984, 'Vardenafil', 'Additive hypotensive effects may occur when phosphodiesterase-5 (PDE5) inhibitors are used with alcohol, as both are mild systemic vasodilators.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458dc19102310c04539900b6f89101f72705618bb5ea6c69cb92b982e8b1791c4fa9a6bbaf14c21a8ea05fd11dd7cbcf19a2456e12d61d5e6cd40c7a986424531f6dcd2af59d41cdc662ed0eaac98ad50d7f455241a3e7b4a4cee48c288cc36266842aeed6613d8a79cc7682cbae0ed20c7fb623acf922ebc8abf3ef104561ea814ec11b327fffd3a39ff1ad9a651c9ddd475f2379bd44e7b57df493cf940a9fde815a5aaa', NULL, X'789c158c410ac3300c04bfb2c716dadef280427bef17145b4102db0a9693e0dfd73e2c2c3becbc63d4a62743fa6e8d8bcfcedbc6a1393275580847c5255cb08bf94854f6c6959c9f0b6ebfcf77b9438be8aacdaa832ae3708eb8b4092805134b0f9063b5390c9c3545781f96ac0127f970269aefd71f1b333510');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3295, 28985, 'Vardenafil', 'Additive hypotensive effects may occur when phosphodiesterase-5 (PDE5) inhibitors are used with alcohol, as both are mild systemic vasodilators.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458dc19102310c04539900b6f89101f72705618bb5ea6c69cb92b982e8b1791c4fa9a6bbaf14c21a8ea05fd11dd7cbcf19a2456e12d61d5e6cd40c7a986424531f6dcd2af59d41cdc662ed0eaac98ad50d7f455241a3e7b4a4cee48c288cc36266842aeed6613d8a79cc7682cbae0ed20c7fb623acf922ebc8abf3ef104561ea814ec11b327fffd3a39ff1ad9a651c9ddd475f2379bd44e7b57df493cf940a9fde815a5aaa', NULL, X'789c158c410ac3300c04bfb2c716dadef280427bef17145b4102db0a9693e0dfd73e2c2c3becbc63d4a62743fa6e8d8bcfcedbc6a1393275580847c5255cb08bf94854f6c6959c9f0b6ebfcf77b9438be8aacdaa832ae3708eb8b4092805134b0f9063b5390c9c3545781f96ac0127f970269aefd71f1b333510');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3296, 28986, 'Vardenafil', 'Additive hypotensive effects may occur when phosphodiesterase-5 (PDE5) inhibitors are used with alcohol, as both are mild systemic vasodilators.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458dc19102310c04539900b6f89101f72705618bb5ea6c69cb92b982e8b1791c4fa9a6bbaf14c21a8ea05fd11dd7cbcf19a2456e12d61d5e6cd40c7a986424531f6dcd2af59d41cdc662ed0eaac98ad50d7f455241a3e7b4a4cee48c288cc36266842aeed6613d8a79cc7682cbae0ed20c7fb623acf922ebc8abf3ef104561ea814ec11b327fffd3a39ff1ad9a651c9ddd475f2379bd44e7b57df493cf940a9fde815a5aaa', NULL, X'789c158c410ac3300c04bfb2c716dadef280427bef17145b4102db0a9693e0dfd73e2c2c3becbc63d4a62743fa6e8d8bcfcedbc6a1393275580847c5255cb08bf94854f6c6959c9f0b6ebfcf77b9438be8aacdaa832ae3708eb8b4092805134b0f9063b5390c9c3545781f96ac0127f970269aefd71f1b333510');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3297, 28987, 'Vardenafil', 'Additive hypotensive effects may occur when phosphodiesterase-5 (PDE5) inhibitors are used with alcohol, as both are mild systemic vasodilators.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458dc19102310c04539900b6f89101f72705618bb5ea6c69cb92b982e8b1791c4fa9a6bbaf14c21a8ea05fd11dd7cbcf19a2456e12d61d5e6cd40c7a986424531f6dcd2af59d41cdc662ed0eaac98ad50d7f455241a3e7b4a4cee48c288cc36266842aeed6613d8a79cc7682cbae0ed20c7fb623acf922ebc8abf3ef104561ea814ec11b327fffd3a39ff1ad9a651c9ddd475f2379bd44e7b57df493cf940a9fde815a5aaa', NULL, X'789c158c410ac3300c04bfb2c716dadef280427bef17145b4102db0a9693e0dfd73e2c2c3becbc63d4a62743fa6e8d8bcfcedbc6a1393275580847c5255cb08bf94854f6c6959c9f0b6ebfcf77b9438be8aacdaa832ae3708eb8b4092805134b0f9063b5390c9c3545781f96ac0127f970269aefd71f1b333510');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3298, 28988, 'Vardenafil', 'Additive hypotensive effects may occur when phosphodiesterase-5 (PDE5) inhibitors are used with alcohol, as both are mild systemic vasodilators.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458dc19102310c04539900b6f89101f72705618bb5ea6c69cb92b982e8b1791c4fa9a6bbaf14c21a8ea05fd11dd7cbcf19a2456e12d61d5e6cd40c7a986424531f6dcd2af59d41cdc662ed0eaac98ad50d7f455241a3e7b4a4cee48c288cc36266842aeed6613d8a79cc7682cbae0ed20c7fb623acf922ebc8abf3ef104561ea814ec11b327fffd3a39ff1ad9a651c9ddd475f2379bd44e7b57df493cf940a9fde815a5aaa', NULL, X'789c158c410ac3300c04bfb2c716dadef280427bef17145b4102db0a9693e0dfd73e2c2c3becbc63d4a62743fa6e8d8bcfcedbc6a1393275580847c5255cb08bf94854f6c6959c9f0b6ebfcf77b9438be8aacdaa832ae3708eb8b4092805134b0f9063b5390c9c3545781f96ac0127f970269aefd71f1b333510');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3299, 28989, 'Vardenafil', 'Additive hypotensive effects may occur when phosphodiesterase-5 (PDE5) inhibitors are used with alcohol, as both are mild systemic vasodilators.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458dc19102310c04539900b6f89101f72705618bb5ea6c69cb92b982e8b1791c4fa9a6bbaf14c21a8ea05fd11dd7cbcf19a2456e12d61d5e6cd40c7a986424531f6dcd2af59d41cdc662ed0eaac98ad50d7f455241a3e7b4a4cee48c288cc36266842aeed6613d8a79cc7682cbae0ed20c7fb623acf922ebc8abf3ef104561ea814ec11b327fffd3a39ff1ad9a651c9ddd475f2379bd44e7b57df493cf940a9fde815a5aaa', NULL, X'789c158c410ac3300c04bfb2c716dadef280427bef17145b4102db0a9693e0dfd73e2c2c3becbc63d4a62743fa6e8d8bcfcedbc6a1393275580847c5255cb08bf94854f6c6959c9f0b6ebfcf77b9438be8aacdaa832ae3708eb8b4092805134b0f9063b5390c9c3545781f96ac0127f970269aefd71f1b333510');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3300, 28990, 'Vardenafil', 'Additive hypotensive effects may occur when phosphodiesterase-5 (PDE5) inhibitors are used with alcohol, as both are mild systemic vasodilators.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458dc19102310c04539900b6f89101f72705618bb5ea6c69cb92b982e8b1791c4fa9a6bbaf14c21a8ea05fd11dd7cbcf19a2456e12d61d5e6cd40c7a986424531f6dcd2af59d41cdc662ed0eaac98ad50d7f455241a3e7b4a4cee48c288cc36266842aeed6613d8a79cc7682cbae0ed20c7fb623acf922ebc8abf3ef104561ea814ec11b327fffd3a39ff1ad9a651c9ddd475f2379bd44e7b57df493cf940a9fde815a5aaa', NULL, X'789c158c410ac3300c04bfb2c716dadef280427bef17145b4102db0a9693e0dfd73e2c2c3becbc63d4a62743fa6e8d8bcfcedbc6a1393275580847c5255cb08bf94854f6c6959c9f0b6ebfcf77b9438be8aacdaa832ae3708eb8b4092805134b0f9063b5390c9c3545781f96ac0127f970269aefd71f1b333510');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3301, 28992, 'Vardenafil', 'Additive hypotensive effects may occur when phosphodiesterase-5 (PDE5) inhibitors are used with alcohol, as both are mild systemic vasodilators.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458dc19102310c04539900b6f89101f72705618bb5ea6c69cb92b982e8b1791c4fa9a6bbaf14c21a8ea05fd11dd7cbcf19a2456e12d61d5e6cd40c7a986424531f6dcd2af59d41cdc662ed0eaac98ad50d7f455241a3e7b4a4cee48c288cc36266842aeed6613d8a79cc7682cbae0ed20c7fb623acf922ebc8abf3ef104561ea814ec11b327fffd3a39ff1ad9a651c9ddd475f2379bd44e7b57df493cf940a9fde815a5aaa', NULL, X'789c158c410ac3300c04bfb2c716dadef280427bef17145b4102db0a9693e0dfd73e2c2c3becbc63d4a62743fa6e8d8bcfcedbc6a1393275580847c5255cb08bf94854f6c6959c9f0b6ebfcf77b9438be8aacdaa832ae3708eb8b4092805134b0f9063b5390c9c3545781f96ac0127f970269aefd71f1b333510');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3302, 28995, 'Vardenafil', 'Additive hypotensive effects may occur when phosphodiesterase-5 (PDE5) inhibitors are used with alcohol, as both are mild systemic vasodilators.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458dc19102310c04539900b6f89101f72705618bb5ea6c69cb92b982e8b1791c4fa9a6bbaf14c21a8ea05fd11dd7cbcf19a2456e12d61d5e6cd40c7a986424531f6dcd2af59d41cdc662ed0eaac98ad50d7f455241a3e7b4a4cee48c288cc36266842aeed6613d8a79cc7682cbae0ed20c7fb623acf922ebc8abf3ef104561ea814ec11b327fffd3a39ff1ad9a651c9ddd475f2379bd44e7b57df493cf940a9fde815a5aaa', NULL, X'789c158c410ac3300c04bfb2c716dadef280427bef17145b4102db0a9693e0dfd73e2c2c3becbc63d4a62743fa6e8d8bcfcedbc6a1393275580847c5255cb08bf94854f6c6959c9f0b6ebfcf77b9438be8aacdaa832ae3708eb8b4092805134b0f9063b5390c9c3545781f96ac0127f970269aefd71f1b333510');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3303, 29005, 'Vardenafil', 'Additive hypotensive effects may occur when phosphodiesterase-5 (PDE5) inhibitors are used with alcohol, as both are mild systemic vasodilators.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458dc19102310c04539900b6f89101f72705618bb5ea6c69cb92b982e8b1791c4fa9a6bbaf14c21a8ea05fd11dd7cbcf19a2456e12d61d5e6cd40c7a986424531f6dcd2af59d41cdc662ed0eaac98ad50d7f455241a3e7b4a4cee48c288cc36266842aeed6613d8a79cc7682cbae0ed20c7fb623acf922ebc8abf3ef104561ea814ec11b327fffd3a39ff1ad9a651c9ddd475f2379bd44e7b57df493cf940a9fde815a5aaa', NULL, X'789c158c410ac3300c04bfb2c716dadef280427bef17145b4102db0a9693e0dfd73e2c2c3becbc63d4a62743fa6e8d8bcfcedbc6a1393275580847c5255cb08bf94854f6c6959c9f0b6ebfcf77b9438be8aacdaa832ae3708eb8b4092805134b0f9063b5390c9c3545781f96ac0127f970269aefd71f1b333510');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3304, 29006, 'Vardenafil', 'Additive hypotensive effects may occur when phosphodiesterase-5 (PDE5) inhibitors are used with alcohol, as both are mild systemic vasodilators.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458dc19102310c04539900b6f89101f72705618bb5ea6c69cb92b982e8b1791c4fa9a6bbaf14c21a8ea05fd11dd7cbcf19a2456e12d61d5e6cd40c7a986424531f6dcd2af59d41cdc662ed0eaac98ad50d7f455241a3e7b4a4cee48c288cc36266842aeed6613d8a79cc7682cbae0ed20c7fb623acf922ebc8abf3ef104561ea814ec11b327fffd3a39ff1ad9a651c9ddd475f2379bd44e7b57df493cf940a9fde815a5aaa', NULL, X'789c158c410ac3300c04bfb2c716dadef280427bef17145b4102db0a9693e0dfd73e2c2c3becbc63d4a62743fa6e8d8bcfcedbc6a1393275580847c5255cb08bf94854f6c6959c9f0b6ebfcf77b9438be8aacdaa832ae3708eb8b4092805134b0f9063b5390c9c3545781f96ac0127f970269aefd71f1b333510');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3305, 29007, 'Vardenafil', 'Additive hypotensive effects may occur when phosphodiesterase-5 (PDE5) inhibitors are used with alcohol, as both are mild systemic vasodilators.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458dc19102310c04539900b6f89101f72705618bb5ea6c69cb92b982e8b1791c4fa9a6bbaf14c21a8ea05fd11dd7cbcf19a2456e12d61d5e6cd40c7a986424531f6dcd2af59d41cdc662ed0eaac98ad50d7f455241a3e7b4a4cee48c288cc36266842aeed6613d8a79cc7682cbae0ed20c7fb623acf922ebc8abf3ef104561ea814ec11b327fffd3a39ff1ad9a651c9ddd475f2379bd44e7b57df493cf940a9fde815a5aaa', NULL, X'789c158c410ac3300c04bfb2c716dadef280427bef17145b4102db0a9693e0dfd73e2c2c3becbc63d4a62743fa6e8d8bcfcedbc6a1393275580847c5255cb08bf94854f6c6959c9f0b6ebfcf77b9438be8aacdaa832ae3708eb8b4092805134b0f9063b5390c9c3545781f96ac0127f970269aefd71f1b333510');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3306, 29144, 'Vardenafil', 'Additive hypotensive effects may occur when phosphodiesterase-5 (PDE5) inhibitors are used with alcohol, as both are mild systemic vasodilators.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458dc19102310c04539900b6f89101f72705618bb5ea6c69cb92b982e8b1791c4fa9a6bbaf14c21a8ea05fd11dd7cbcf19a2456e12d61d5e6cd40c7a986424531f6dcd2af59d41cdc662ed0eaac98ad50d7f455241a3e7b4a4cee48c288cc36266842aeed6613d8a79cc7682cbae0ed20c7fb623acf922ebc8abf3ef104561ea814ec11b327fffd3a39ff1ad9a651c9ddd475f2379bd44e7b57df493cf940a9fde815a5aaa', NULL, X'789c158c410ac3300c04bfb2c716dadef280427bef17145b4102db0a9693e0dfd73e2c2c3becbc63d4a62743fa6e8d8bcfcedbc6a1393275580847c5255cb08bf94854f6c6959c9f0b6ebfcf77b9438be8aacdaa832ae3708eb8b4092805134b0f9063b5390c9c3545781f96ac0127f970269aefd71f1b333510');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3307, 29296, 'Vardenafil', 'Additive hypotensive effects may occur when phosphodiesterase-5 (PDE5) inhibitors are used with alcohol, as both are mild systemic vasodilators.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458dc19102310c04539900b6f89101f72705618bb5ea6c69cb92b982e8b1791c4fa9a6bbaf14c21a8ea05fd11dd7cbcf19a2456e12d61d5e6cd40c7a986424531f6dcd2af59d41cdc662ed0eaac98ad50d7f455241a3e7b4a4cee48c288cc36266842aeed6613d8a79cc7682cbae0ed20c7fb623acf922ebc8abf3ef104561ea814ec11b327fffd3a39ff1ad9a651c9ddd475f2379bd44e7b57df493cf940a9fde815a5aaa', NULL, X'789c158c410ac3300c04bfb2c716dadef280427bef17145b4102db0a9693e0dfd73e2c2c3becbc63d4a62743fa6e8d8bcfcedbc6a1393275580847c5255cb08bf94854f6c6959c9f0b6ebfcf77b9438be8aacdaa832ae3708eb8b4092805134b0f9063b5390c9c3545781f96ac0127f970269aefd71f1b333510');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3308, 31180, 'Vardenafil', 'Additive hypotensive effects may occur when phosphodiesterase-5 (PDE5) inhibitors are used with alcohol, as both are mild systemic vasodilators.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458dc19102310c04539900b6f89101f72705618bb5ea6c69cb92b982e8b1791c4fa9a6bbaf14c21a8ea05fd11dd7cbcf19a2456e12d61d5e6cd40c7a986424531f6dcd2af59d41cdc662ed0eaac98ad50d7f455241a3e7b4a4cee48c288cc36266842aeed6613d8a79cc7682cbae0ed20c7fb623acf922ebc8abf3ef104561ea814ec11b327fffd3a39ff1ad9a651c9ddd475f2379bd44e7b57df493cf940a9fde815a5aaa', NULL, X'789c158c410ac3300c04bfb2c716dadef280427bef17145b4102db0a9693e0dfd73e2c2c3becbc63d4a62743fa6e8d8bcfcedbc6a1393275580847c5255cb08bf94854f6c6959c9f0b6ebfcf77b9438be8aacdaa832ae3708eb8b4092805134b0f9063b5390c9c3545781f96ac0127f970269aefd71f1b333510');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3309, 32236, 'Vardenafil', 'Additive hypotensive effects may occur when phosphodiesterase-5 (PDE5) inhibitors are used with alcohol, as both are mild systemic vasodilators.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458dc19102310c04539900b6f89101f72705618bb5ea6c69cb92b982e8b1791c4fa9a6bbaf14c21a8ea05fd11dd7cbcf19a2456e12d61d5e6cd40c7a986424531f6dcd2af59d41cdc662ed0eaac98ad50d7f455241a3e7b4a4cee48c288cc36266842aeed6613d8a79cc7682cbae0ed20c7fb623acf922ebc8abf3ef104561ea814ec11b327fffd3a39ff1ad9a651c9ddd475f2379bd44e7b57df493cf940a9fde815a5aaa', NULL, X'789c158c410ac3300c04bfb2c716dadef280427bef17145b4102db0a9693e0dfd73e2c2c3becbc63d4a62743fa6e8d8bcfcedbc6a1393275580847c5255cb08bf94854f6c6959c9f0b6ebfcf77b9438be8aacdaa832ae3708eb8b4092805134b0f9063b5390c9c3545781f96ac0127f970269aefd71f1b333510');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3310, 33836, 'Vardenafil', 'Additive hypotensive effects may occur when phosphodiesterase-5 (PDE5) inhibitors are used with alcohol, as both are mild systemic vasodilators.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458dc19102310c04539900b6f89101f72705618bb5ea6c69cb92b982e8b1791c4fa9a6bbaf14c21a8ea05fd11dd7cbcf19a2456e12d61d5e6cd40c7a986424531f6dcd2af59d41cdc662ed0eaac98ad50d7f455241a3e7b4a4cee48c288cc36266842aeed6613d8a79cc7682cbae0ed20c7fb623acf922ebc8abf3ef104561ea814ec11b327fffd3a39ff1ad9a651c9ddd475f2379bd44e7b57df493cf940a9fde815a5aaa', NULL, X'789c158c410ac3300c04bfb2c716dadef280427bef17145b4102db0a9693e0dfd73e2c2c3becbc63d4a62743fa6e8d8bcfcedbc6a1393275580847c5255cb08bf94854f6c6959c9f0b6ebfcf77b9438be8aacdaa832ae3708eb8b4092805134b0f9063b5390c9c3545781f96ac0127f970269aefd71f1b333510');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3311, 33837, 'Vardenafil', 'Additive hypotensive effects may occur when phosphodiesterase-5 (PDE5) inhibitors are used with alcohol, as both are mild systemic vasodilators.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458dc19102310c04539900b6f89101f72705618bb5ea6c69cb92b982e8b1791c4fa9a6bbaf14c21a8ea05fd11dd7cbcf19a2456e12d61d5e6cd40c7a986424531f6dcd2af59d41cdc662ed0eaac98ad50d7f455241a3e7b4a4cee48c288cc36266842aeed6613d8a79cc7682cbae0ed20c7fb623acf922ebc8abf3ef104561ea814ec11b327fffd3a39ff1ad9a651c9ddd475f2379bd44e7b57df493cf940a9fde815a5aaa', NULL, X'789c158c410ac3300c04bfb2c716dadef280427bef17145b4102db0a9693e0dfd73e2c2c3becbc63d4a62743fa6e8d8bcfcedbc6a1393275580847c5255cb08bf94854f6c6959c9f0b6ebfcf77b9438be8aacdaa832ae3708eb8b4092805134b0f9063b5390c9c3545781f96ac0127f970269aefd71f1b333510');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3312, 7255, 'Vardenafil', 'Grapefruit juice may increase the plasma concentrations of orally administered drugs that are substrates of the CYP450 3A4 isoenzyme.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.  Because grapefruit juice inhibits primarily intestinal rather than hepatic CYP450 3A4, the magnitude of interaction is greatest for those drugs that undergo significant presystemic metabolism by CYP450 3A4 (i.e., drugs with low oral bioavailability). In general, the effect of grapefruit juice is concentration-, dose- and preparation-dependent, and can vary widely among brands.', 'grapefruit juice', 'Moderate', '', 'DDInter', 0, X'789c7d8f4b4e04310c44af52271821311c00b160c96c59ba13276d944f2b7666e8dbe30604ac585a65fbbdba90093753dcd68ec179161a6547e84d6765e4411ba731c5d0c7dfe96d4a60e8da67895818b537b13e3822f922c52b0f65704a1cfc39b5082ac647be15d24a0721387838df59e80971ccacb0950cb3451eb94325374912a819b6c1baab719580ca464b2fa215cb8ea7d7cbf9e10ef78fe713f0fceb7850ff51a66b97e842927c13d25c8fc2610351e8d4cdd539facb97412df3f7bd67ad1bf8fd2b86f59f53dcc4562fc0defcb3cce903c9bb8157', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3313, 7519, 'Vardenafil', 'Grapefruit juice may increase the plasma concentrations of orally administered drugs that are substrates of the CYP450 3A4 isoenzyme.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.  Because grapefruit juice inhibits primarily intestinal rather than hepatic CYP450 3A4, the magnitude of interaction is greatest for those drugs that undergo significant presystemic metabolism by CYP450 3A4 (i.e., drugs with low oral bioavailability). In general, the effect of grapefruit juice is concentration-, dose- and preparation-dependent, and can vary widely among brands.', 'grapefruit juice', 'Moderate', '', 'DDInter', 0, X'789c7d8f4b4e04310c44af52271821311c00b160c96c59ba13276d944f2b7666e8dbe30604ac585a65fbbdba90093753dcd68ec179161a6547e84d6765e4411ba731c5d0c7dfe96d4a60e8da67895818b537b13e3822f922c52b0f65704a1cfc39b5082ac647be15d24a0721387838df59e80971ccacb0950cb3451eb94325374912a819b6c1baab719580ca464b2fa215cb8ea7d7cbf9e10ef78fe713f0fceb7850ff51a66b97e842927c13d25c8fc2610351e8d4cdd539facb97412df3f7bd67ad1bf8fd2b86f59f53dcc4562fc0defcb3cce903c9bb8157', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3314, 10684, 'Vardenafil', 'Grapefruit juice may increase the plasma concentrations of orally administered drugs that are substrates of the CYP450 3A4 isoenzyme.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.  Because grapefruit juice inhibits primarily intestinal rather than hepatic CYP450 3A4, the magnitude of interaction is greatest for those drugs that undergo significant presystemic metabolism by CYP450 3A4 (i.e., drugs with low oral bioavailability). In general, the effect of grapefruit juice is concentration-, dose- and preparation-dependent, and can vary widely among brands.', 'grapefruit juice', 'Moderate', '', 'DDInter', 0, X'789c7d8f4b4e04310c44af52271821311c00b160c96c59ba13276d944f2b7666e8dbe30604ac585a65fbbdba90093753dcd68ec179161a6547e84d6765e4411ba731c5d0c7dfe96d4a60e8da67895818b537b13e3822f922c52b0f65704a1cfc39b5082ac647be15d24a0721387838df59e80971ccacb0950cb3451eb94325374912a819b6c1baab719580ca464b2fa215cb8ea7d7cbf9e10ef78fe713f0fceb7850ff51a66b97e842927c13d25c8fc2610351e8d4cdd539facb97412df3f7bd67ad1bf8fd2b86f59f53dcc4562fc0defcb3cce903c9bb8157', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3315, 18514, 'Vardenafil', 'Grapefruit juice may increase the plasma concentrations of orally administered drugs that are substrates of the CYP450 3A4 isoenzyme.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.  Because grapefruit juice inhibits primarily intestinal rather than hepatic CYP450 3A4, the magnitude of interaction is greatest for those drugs that undergo significant presystemic metabolism by CYP450 3A4 (i.e., drugs with low oral bioavailability). In general, the effect of grapefruit juice is concentration-, dose- and preparation-dependent, and can vary widely among brands.', 'grapefruit juice', 'Moderate', '', 'DDInter', 0, X'789c7d8f4b4e04310c44af52271821311c00b160c96c59ba13276d944f2b7666e8dbe30604ac585a65fbbdba90093753dcd68ec179161a6547e84d6765e4411ba731c5d0c7dfe96d4a60e8da67895818b537b13e3822f922c52b0f65704a1cfc39b5082ac647be15d24a0721387838df59e80971ccacb0950cb3451eb94325374912a819b6c1baab719580ca464b2fa215cb8ea7d7cbf9e10ef78fe713f0fceb7850ff51a66b97e842927c13d25c8fc2610351e8d4cdd539facb97412df3f7bd67ad1bf8fd2b86f59f53dcc4562fc0defcb3cce903c9bb8157', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3316, 25111, 'Vardenafil', 'Grapefruit juice may increase the plasma concentrations of orally administered drugs that are substrates of the CYP450 3A4 isoenzyme.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.  Because grapefruit juice inhibits primarily intestinal rather than hepatic CYP450 3A4, the magnitude of interaction is greatest for those drugs that undergo significant presystemic metabolism by CYP450 3A4 (i.e., drugs with low oral bioavailability). In general, the effect of grapefruit juice is concentration-, dose- and preparation-dependent, and can vary widely among brands.', 'grapefruit juice', 'Moderate', '', 'DDInter', 0, X'789c7d8f4b4e04310c44af52271821311c00b160c96c59ba13276d944f2b7666e8dbe30604ac585a65fbbdba90093753dcd68ec179161a6547e84d6765e4411ba731c5d0c7dfe96d4a60e8da67895818b537b13e3822f922c52b0f65704a1cfc39b5082ac647be15d24a0721387838df59e80971ccacb0950cb3451eb94325374912a819b6c1baab719580ca464b2fa215cb8ea7d7cbf9e10ef78fe713f0fceb7850ff51a66b97e842927c13d25c8fc2610351e8d4cdd539facb97412df3f7bd67ad1bf8fd2b86f59f53dcc4562fc0defcb3cce903c9bb8157', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3317, 25112, 'Vardenafil', 'Grapefruit juice may increase the plasma concentrations of orally administered drugs that are substrates of the CYP450 3A4 isoenzyme.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.  Because grapefruit juice inhibits primarily intestinal rather than hepatic CYP450 3A4, the magnitude of interaction is greatest for those drugs that undergo significant presystemic metabolism by CYP450 3A4 (i.e., drugs with low oral bioavailability). In general, the effect of grapefruit juice is concentration-, dose- and preparation-dependent, and can vary widely among brands.', 'grapefruit juice', 'Moderate', '', 'DDInter', 0, X'789c7d8f4b4e04310c44af52271821311c00b160c96c59ba13276d944f2b7666e8dbe30604ac585a65fbbdba90093753dcd68ec179161a6547e84d6765e4411ba731c5d0c7dfe96d4a60e8da67895818b537b13e3822f922c52b0f65704a1cfc39b5082ac647be15d24a0721387838df59e80971ccacb0950cb3451eb94325374912a819b6c1baab719580ca464b2fa215cb8ea7d7cbf9e10ef78fe713f0fceb7850ff51a66b97e842927c13d25c8fc2610351e8d4cdd539facb97412df3f7bd67ad1bf8fd2b86f59f53dcc4562fc0defcb3cce903c9bb8157', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3318, 25113, 'Vardenafil', 'Grapefruit juice may increase the plasma concentrations of orally administered drugs that are substrates of the CYP450 3A4 isoenzyme.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.  Because grapefruit juice inhibits primarily intestinal rather than hepatic CYP450 3A4, the magnitude of interaction is greatest for those drugs that undergo significant presystemic metabolism by CYP450 3A4 (i.e., drugs with low oral bioavailability). In general, the effect of grapefruit juice is concentration-, dose- and preparation-dependent, and can vary widely among brands.', 'grapefruit juice', 'Moderate', '', 'DDInter', 0, X'789c7d8f4b4e04310c44af52271821311c00b160c96c59ba13276d944f2b7666e8dbe30604ac585a65fbbdba90093753dcd68ec179161a6547e84d6765e4411ba731c5d0c7dfe96d4a60e8da67895818b537b13e3822f922c52b0f65704a1cfc39b5082ac647be15d24a0721387838df59e80971ccacb0950cb3451eb94325374912a819b6c1baab719580ca464b2fa215cb8ea7d7cbf9e10ef78fe713f0fceb7850ff51a66b97e842927c13d25c8fc2610351e8d4cdd539facb97412df3f7bd67ad1bf8fd2b86f59f53dcc4562fc0defcb3cce903c9bb8157', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3319, 25114, 'Vardenafil', 'Grapefruit juice may increase the plasma concentrations of orally administered drugs that are substrates of the CYP450 3A4 isoenzyme.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.  Because grapefruit juice inhibits primarily intestinal rather than hepatic CYP450 3A4, the magnitude of interaction is greatest for those drugs that undergo significant presystemic metabolism by CYP450 3A4 (i.e., drugs with low oral bioavailability). In general, the effect of grapefruit juice is concentration-, dose- and preparation-dependent, and can vary widely among brands.', 'grapefruit juice', 'Moderate', '', 'DDInter', 0, X'789c7d8f4b4e04310c44af52271821311c00b160c96c59ba13276d944f2b7666e8dbe30604ac585a65fbbdba90093753dcd68ec179161a6547e84d6765e4411ba731c5d0c7dfe96d4a60e8da67895818b537b13e3822f922c52b0f65704a1cfc39b5082ac647be15d24a0721387838df59e80971ccacb0950cb3451eb94325374912a819b6c1baab719580ca464b2fa215cb8ea7d7cbf9e10ef78fe713f0fceb7850ff51a66b97e842927c13d25c8fc2610351e8d4cdd539facb97412df3f7bd67ad1bf8fd2b86f59f53dcc4562fc0defcb3cce903c9bb8157', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3320, 25115, 'Vardenafil', 'Grapefruit juice may increase the plasma concentrations of orally administered drugs that are substrates of the CYP450 3A4 isoenzyme.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.  Because grapefruit juice inhibits primarily intestinal rather than hepatic CYP450 3A4, the magnitude of interaction is greatest for those drugs that undergo significant presystemic metabolism by CYP450 3A4 (i.e., drugs with low oral bioavailability). In general, the effect of grapefruit juice is concentration-, dose- and preparation-dependent, and can vary widely among brands.', 'grapefruit juice', 'Moderate', '', 'DDInter', 0, X'789c7d8f4b4e04310c44af52271821311c00b160c96c59ba13276d944f2b7666e8dbe30604ac585a65fbbdba90093753dcd68ec179161a6547e84d6765e4411ba731c5d0c7dfe96d4a60e8da67895818b537b13e3822f922c52b0f65704a1cfc39b5082ac647be15d24a0721387838df59e80971ccacb0950cb3451eb94325374912a819b6c1baab719580ca464b2fa215cb8ea7d7cbf9e10ef78fe713f0fceb7850ff51a66b97e842927c13d25c8fc2610351e8d4cdd539facb97412df3f7bd67ad1bf8fd2b86f59f53dcc4562fc0defcb3cce903c9bb8157', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3321, 25778, 'Vardenafil', 'Grapefruit juice may increase the plasma concentrations of orally administered drugs that are substrates of the CYP450 3A4 isoenzyme.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.  Because grapefruit juice inhibits primarily intestinal rather than hepatic CYP450 3A4, the magnitude of interaction is greatest for those drugs that undergo significant presystemic metabolism by CYP450 3A4 (i.e., drugs with low oral bioavailability). In general, the effect of grapefruit juice is concentration-, dose- and preparation-dependent, and can vary widely among brands.', 'grapefruit juice', 'Moderate', '', 'DDInter', 0, X'789c7d8f4b4e04310c44af52271821311c00b160c96c59ba13276d944f2b7666e8dbe30604ac585a65fbbdba90093753dcd68ec179161a6547e84d6765e4411ba731c5d0c7dfe96d4a60e8da67895818b537b13e3822f922c52b0f65704a1cfc39b5082ac647be15d24a0721387838df59e80971ccacb0950cb3451eb94325374912a819b6c1baab719580ca464b2fa215cb8ea7d7cbf9e10ef78fe713f0fceb7850ff51a66b97e842927c13d25c8fc2610351e8d4cdd539facb97412df3f7bd67ad1bf8fd2b86f59f53dcc4562fc0defcb3cce903c9bb8157', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3322, 26260, 'Vardenafil', 'Grapefruit juice may increase the plasma concentrations of orally administered drugs that are substrates of the CYP450 3A4 isoenzyme.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.  Because grapefruit juice inhibits primarily intestinal rather than hepatic CYP450 3A4, the magnitude of interaction is greatest for those drugs that undergo significant presystemic metabolism by CYP450 3A4 (i.e., drugs with low oral bioavailability). In general, the effect of grapefruit juice is concentration-, dose- and preparation-dependent, and can vary widely among brands.', 'grapefruit juice', 'Moderate', '', 'DDInter', 0, X'789c7d8f4b4e04310c44af52271821311c00b160c96c59ba13276d944f2b7666e8dbe30604ac585a65fbbdba90093753dcd68ec179161a6547e84d6765e4411ba731c5d0c7dfe96d4a60e8da67895818b537b13e3822f922c52b0f65704a1cfc39b5082ac647be15d24a0721387838df59e80971ccacb0950cb3451eb94325374912a819b6c1baab719580ca464b2fa215cb8ea7d7cbf9e10ef78fe713f0fceb7850ff51a66b97e842927c13d25c8fc2610351e8d4cdd539facb97412df3f7bd67ad1bf8fd2b86f59f53dcc4562fc0defcb3cce903c9bb8157', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3323, 26261, 'Vardenafil', 'Grapefruit juice may increase the plasma concentrations of orally administered drugs that are substrates of the CYP450 3A4 isoenzyme.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.  Because grapefruit juice inhibits primarily intestinal rather than hepatic CYP450 3A4, the magnitude of interaction is greatest for those drugs that undergo significant presystemic metabolism by CYP450 3A4 (i.e., drugs with low oral bioavailability). In general, the effect of grapefruit juice is concentration-, dose- and preparation-dependent, and can vary widely among brands.', 'grapefruit juice', 'Moderate', '', 'DDInter', 0, X'789c7d8f4b4e04310c44af52271821311c00b160c96c59ba13276d944f2b7666e8dbe30604ac585a65fbbdba90093753dcd68ec179161a6547e84d6765e4411ba731c5d0c7dfe96d4a60e8da67895818b537b13e3822f922c52b0f65704a1cfc39b5082ac647be15d24a0721387838df59e80971ccacb0950cb3451eb94325374912a819b6c1baab719580ca464b2fa215cb8ea7d7cbf9e10ef78fe713f0fceb7850ff51a66b97e842927c13d25c8fc2610351e8d4cdd539facb97412df3f7bd67ad1bf8fd2b86f59f53dcc4562fc0defcb3cce903c9bb8157', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3324, 26353, 'Vardenafil', 'Grapefruit juice may increase the plasma concentrations of orally administered drugs that are substrates of the CYP450 3A4 isoenzyme.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.  Because grapefruit juice inhibits primarily intestinal rather than hepatic CYP450 3A4, the magnitude of interaction is greatest for those drugs that undergo significant presystemic metabolism by CYP450 3A4 (i.e., drugs with low oral bioavailability). In general, the effect of grapefruit juice is concentration-, dose- and preparation-dependent, and can vary widely among brands.', 'grapefruit juice', 'Moderate', '', 'DDInter', 0, X'789c7d8f4b4e04310c44af52271821311c00b160c96c59ba13276d944f2b7666e8dbe30604ac585a65fbbdba90093753dcd68ec179161a6547e84d6765e4411ba731c5d0c7dfe96d4a60e8da67895818b537b13e3822f922c52b0f65704a1cfc39b5082ac647be15d24a0721387838df59e80971ccacb0950cb3451eb94325374912a819b6c1baab719580ca464b2fa215cb8ea7d7cbf9e10ef78fe713f0fceb7850ff51a66b97e842927c13d25c8fc2610351e8d4cdd539facb97412df3f7bd67ad1bf8fd2b86f59f53dcc4562fc0defcb3cce903c9bb8157', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3325, 28605, 'Vardenafil', 'Grapefruit juice may increase the plasma concentrations of orally administered drugs that are substrates of the CYP450 3A4 isoenzyme.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.  Because grapefruit juice inhibits primarily intestinal rather than hepatic CYP450 3A4, the magnitude of interaction is greatest for those drugs that undergo significant presystemic metabolism by CYP450 3A4 (i.e., drugs with low oral bioavailability). In general, the effect of grapefruit juice is concentration-, dose- and preparation-dependent, and can vary widely among brands.', 'grapefruit juice', 'Moderate', '', 'DDInter', 0, X'789c7d8f4b4e04310c44af52271821311c00b160c96c59ba13276d944f2b7666e8dbe30604ac585a65fbbdba90093753dcd68ec179161a6547e84d6765e4411ba731c5d0c7dfe96d4a60e8da67895818b537b13e3822f922c52b0f65704a1cfc39b5082ac647be15d24a0721387838df59e80971ccacb0950cb3451eb94325374912a819b6c1baab719580ca464b2fa215cb8ea7d7cbf9e10ef78fe713f0fceb7850ff51a66b97e842927c13d25c8fc2610351e8d4cdd539facb97412df3f7bd67ad1bf8fd2b86f59f53dcc4562fc0defcb3cce903c9bb8157', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3326, 28981, 'Vardenafil', 'Grapefruit juice may increase the plasma concentrations of orally administered drugs that are substrates of the CYP450 3A4 isoenzyme.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.  Because grapefruit juice inhibits primarily intestinal rather than hepatic CYP450 3A4, the magnitude of interaction is greatest for those drugs that undergo significant presystemic metabolism by CYP450 3A4 (i.e., drugs with low oral bioavailability). In general, the effect of grapefruit juice is concentration-, dose- and preparation-dependent, and can vary widely among brands.', 'grapefruit juice', 'Moderate', '', 'DDInter', 0, X'789c7d8f4b4e04310c44af52271821311c00b160c96c59ba13276d944f2b7666e8dbe30604ac585a65fbbdba90093753dcd68ec179161a6547e84d6765e4411ba731c5d0c7dfe96d4a60e8da67895818b537b13e3822f922c52b0f65704a1cfc39b5082ac647be15d24a0721387838df59e80971ccacb0950cb3451eb94325374912a819b6c1baab719580ca464b2fa215cb8ea7d7cbf9e10ef78fe713f0fceb7850ff51a66b97e842927c13d25c8fc2610351e8d4cdd539facb97412df3f7bd67ad1bf8fd2b86f59f53dcc4562fc0defcb3cce903c9bb8157', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3327, 28982, 'Vardenafil', 'Grapefruit juice may increase the plasma concentrations of orally administered drugs that are substrates of the CYP450 3A4 isoenzyme.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.  Because grapefruit juice inhibits primarily intestinal rather than hepatic CYP450 3A4, the magnitude of interaction is greatest for those drugs that undergo significant presystemic metabolism by CYP450 3A4 (i.e., drugs with low oral bioavailability). In general, the effect of grapefruit juice is concentration-, dose- and preparation-dependent, and can vary widely among brands.', 'grapefruit juice', 'Moderate', '', 'DDInter', 0, X'789c7d8f4b4e04310c44af52271821311c00b160c96c59ba13276d944f2b7666e8dbe30604ac585a65fbbdba90093753dcd68ec179161a6547e84d6765e4411ba731c5d0c7dfe96d4a60e8da67895818b537b13e3822f922c52b0f65704a1cfc39b5082ac647be15d24a0721387838df59e80971ccacb0950cb3451eb94325374912a819b6c1baab719580ca464b2fa215cb8ea7d7cbf9e10ef78fe713f0fceb7850ff51a66b97e842927c13d25c8fc2610351e8d4cdd539facb97412df3f7bd67ad1bf8fd2b86f59f53dcc4562fc0defcb3cce903c9bb8157', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3328, 28983, 'Vardenafil', 'Grapefruit juice may increase the plasma concentrations of orally administered drugs that are substrates of the CYP450 3A4 isoenzyme.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.  Because grapefruit juice inhibits primarily intestinal rather than hepatic CYP450 3A4, the magnitude of interaction is greatest for those drugs that undergo significant presystemic metabolism by CYP450 3A4 (i.e., drugs with low oral bioavailability). In general, the effect of grapefruit juice is concentration-, dose- and preparation-dependent, and can vary widely among brands.', 'grapefruit juice', 'Moderate', '', 'DDInter', 0, X'789c7d8f4b4e04310c44af52271821311c00b160c96c59ba13276d944f2b7666e8dbe30604ac585a65fbbdba90093753dcd68ec179161a6547e84d6765e4411ba731c5d0c7dfe96d4a60e8da67895818b537b13e3822f922c52b0f65704a1cfc39b5082ac647be15d24a0721387838df59e80971ccacb0950cb3451eb94325374912a819b6c1baab719580ca464b2fa215cb8ea7d7cbf9e10ef78fe713f0fceb7850ff51a66b97e842927c13d25c8fc2610351e8d4cdd539facb97412df3f7bd67ad1bf8fd2b86f59f53dcc4562fc0defcb3cce903c9bb8157', NULL, X'789c6592cd4ec4300c845fc54790762b249607000e881b072e1cddc46d8df253d9e9aecad36397152c704d3233df4cfb2438d3200b37785f3810645c814b1042256813c19c503342a8255069828d6b51a80354c19456c098b9b036128a106519d564d8008540975e5d429bc0dd1edf5e0e7737707b7f00d64ae563cdd401bc7a90d4b9aa99640a139a65b627c63271cf1eea163ff27da6c8e61c6160d1b69f51d5940dfb9a3669d9f2c6a5c1c938a15f219034b4f350f35c9712d52249ad943f1ebf87309c070ab858fff1ef3a671a577246e1e46359bdc6051358d389c4eb179868b6a9c205f16e03ca38166e4b24afe35ac1b0b5b3aea3adee66305477b1312e07356292b182b2390c1cd0c0bdc06adb674bba286f652f86bee28ebaddd9eac46d82544fdbe7839e2b1e9113f69cb8add71d3cdb14548c2a7df1d23050680efb7f0cfdfd57ec2dc398f780253ad98ce7f34833197c69bbedcac8e188b21a4b24ff83722d23f46277da7d022ee9ed60');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3329, 28984, 'Vardenafil', 'Grapefruit juice may increase the plasma concentrations of orally administered drugs that are substrates of the CYP450 3A4 isoenzyme.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.  Because grapefruit juice inhibits primarily intestinal rather than hepatic CYP450 3A4, the magnitude of interaction is greatest for those drugs that undergo significant presystemic metabolism by CYP450 3A4 (i.e., drugs with low oral bioavailability). In general, the effect of grapefruit juice is concentration-, dose- and preparation-dependent, and can vary widely among brands.', 'grapefruit juice', 'Moderate', '', 'DDInter', 0, X'789c7d8f4b4e04310c44af52271821311c00b160c96c59ba13276d944f2b7666e8dbe30604ac585a65fbbdba90093753dcd68ec179161a6547e84d6765e4411ba731c5d0c7dfe96d4a60e8da67895818b537b13e3822f922c52b0f65704a1cfc39b5082ac647be15d24a0721387838df59e80971ccacb0950cb3451eb94325374912a819b6c1baab719580ca464b2fa215cb8ea7d7cbf9e10ef78fe713f0fceb7850ff51a66b97e842927c13d25c8fc2610351e8d4cdd539facb97412df3f7bd67ad1bf8fd2b86f59f53dcc4562fc0defcb3cce903c9bb8157', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3330, 28985, 'Vardenafil', 'Grapefruit juice may increase the plasma concentrations of orally administered drugs that are substrates of the CYP450 3A4 isoenzyme.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.  Because grapefruit juice inhibits primarily intestinal rather than hepatic CYP450 3A4, the magnitude of interaction is greatest for those drugs that undergo significant presystemic metabolism by CYP450 3A4 (i.e., drugs with low oral bioavailability). In general, the effect of grapefruit juice is concentration-, dose- and preparation-dependent, and can vary widely among brands.', 'grapefruit juice', 'Moderate', '', 'DDInter', 0, X'789c7d8f4b4e04310c44af52271821311c00b160c96c59ba13276d944f2b7666e8dbe30604ac585a65fbbdba90093753dcd68ec179161a6547e84d6765e4411ba731c5d0c7dfe96d4a60e8da67895818b537b13e3822f922c52b0f65704a1cfc39b5082ac647be15d24a0721387838df59e80971ccacb0950cb3451eb94325374912a819b6c1baab719580ca464b2fa215cb8ea7d7cbf9e10ef78fe713f0fceb7850ff51a66b97e842927c13d25c8fc2610351e8d4cdd539facb97412df3f7bd67ad1bf8fd2b86f59f53dcc4562fc0defcb3cce903c9bb8157', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3331, 28986, 'Vardenafil', 'Grapefruit juice may increase the plasma concentrations of orally administered drugs that are substrates of the CYP450 3A4 isoenzyme.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.  Because grapefruit juice inhibits primarily intestinal rather than hepatic CYP450 3A4, the magnitude of interaction is greatest for those drugs that undergo significant presystemic metabolism by CYP450 3A4 (i.e., drugs with low oral bioavailability). In general, the effect of grapefruit juice is concentration-, dose- and preparation-dependent, and can vary widely among brands.', 'grapefruit juice', 'Moderate', '', 'DDInter', 0, X'789c7d8f4b4e04310c44af52271821311c00b160c96c59ba13276d944f2b7666e8dbe30604ac585a65fbbdba90093753dcd68ec179161a6547e84d6765e4411ba731c5d0c7dfe96d4a60e8da67895818b537b13e3822f922c52b0f65704a1cfc39b5082ac647be15d24a0721387838df59e80971ccacb0950cb3451eb94325374912a819b6c1baab719580ca464b2fa215cb8ea7d7cbf9e10ef78fe713f0fceb7850ff51a66b97e842927c13d25c8fc2610351e8d4cdd539facb97412df3f7bd67ad1bf8fd2b86f59f53dcc4562fc0defcb3cce903c9bb8157', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3332, 28987, 'Vardenafil', 'Grapefruit juice may increase the plasma concentrations of orally administered drugs that are substrates of the CYP450 3A4 isoenzyme.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.  Because grapefruit juice inhibits primarily intestinal rather than hepatic CYP450 3A4, the magnitude of interaction is greatest for those drugs that undergo significant presystemic metabolism by CYP450 3A4 (i.e., drugs with low oral bioavailability). In general, the effect of grapefruit juice is concentration-, dose- and preparation-dependent, and can vary widely among brands.', 'grapefruit juice', 'Moderate', '', 'DDInter', 0, X'789c7d8f4b4e04310c44af52271821311c00b160c96c59ba13276d944f2b7666e8dbe30604ac585a65fbbdba90093753dcd68ec179161a6547e84d6765e4411ba731c5d0c7dfe96d4a60e8da67895818b537b13e3822f922c52b0f65704a1cfc39b5082ac647be15d24a0721387838df59e80971ccacb0950cb3451eb94325374912a819b6c1baab719580ca464b2fa215cb8ea7d7cbf9e10ef78fe713f0fceb7850ff51a66b97e842927c13d25c8fc2610351e8d4cdd539facb97412df3f7bd67ad1bf8fd2b86f59f53dcc4562fc0defcb3cce903c9bb8157', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3333, 28988, 'Vardenafil', 'Grapefruit juice may increase the plasma concentrations of orally administered drugs that are substrates of the CYP450 3A4 isoenzyme.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.  Because grapefruit juice inhibits primarily intestinal rather than hepatic CYP450 3A4, the magnitude of interaction is greatest for those drugs that undergo significant presystemic metabolism by CYP450 3A4 (i.e., drugs with low oral bioavailability). In general, the effect of grapefruit juice is concentration-, dose- and preparation-dependent, and can vary widely among brands.', 'grapefruit juice', 'Moderate', '', 'DDInter', 0, X'789c7d8f4b4e04310c44af52271821311c00b160c96c59ba13276d944f2b7666e8dbe30604ac585a65fbbdba90093753dcd68ec179161a6547e84d6765e4411ba731c5d0c7dfe96d4a60e8da67895818b537b13e3822f922c52b0f65704a1cfc39b5082ac647be15d24a0721387838df59e80971ccacb0950cb3451eb94325374912a819b6c1baab719580ca464b2fa215cb8ea7d7cbf9e10ef78fe713f0fceb7850ff51a66b97e842927c13d25c8fc2610351e8d4cdd539facb97412df3f7bd67ad1bf8fd2b86f59f53dcc4562fc0defcb3cce903c9bb8157', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3334, 28989, 'Vardenafil', 'Grapefruit juice may increase the plasma concentrations of orally administered drugs that are substrates of the CYP450 3A4 isoenzyme.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.  Because grapefruit juice inhibits primarily intestinal rather than hepatic CYP450 3A4, the magnitude of interaction is greatest for those drugs that undergo significant presystemic metabolism by CYP450 3A4 (i.e., drugs with low oral bioavailability). In general, the effect of grapefruit juice is concentration-, dose- and preparation-dependent, and can vary widely among brands.', 'grapefruit juice', 'Moderate', '', 'DDInter', 0, X'789c7d8f4b4e04310c44af52271821311c00b160c96c59ba13276d944f2b7666e8dbe30604ac585a65fbbdba90093753dcd68ec179161a6547e84d6765e4411ba731c5d0c7dfe96d4a60e8da67895818b537b13e3822f922c52b0f65704a1cfc39b5082ac647be15d24a0721387838df59e80971ccacb0950cb3451eb94325374912a819b6c1baab719580ca464b2fa215cb8ea7d7cbf9e10ef78fe713f0fceb7850ff51a66b97e842927c13d25c8fc2610351e8d4cdd539facb97412df3f7bd67ad1bf8fd2b86f59f53dcc4562fc0defcb3cce903c9bb8157', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3335, 28990, 'Vardenafil', 'Grapefruit juice may increase the plasma concentrations of orally administered drugs that are substrates of the CYP450 3A4 isoenzyme.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.  Because grapefruit juice inhibits primarily intestinal rather than hepatic CYP450 3A4, the magnitude of interaction is greatest for those drugs that undergo significant presystemic metabolism by CYP450 3A4 (i.e., drugs with low oral bioavailability). In general, the effect of grapefruit juice is concentration-, dose- and preparation-dependent, and can vary widely among brands.', 'grapefruit juice', 'Moderate', '', 'DDInter', 0, X'789c7d8f4b4e04310c44af52271821311c00b160c96c59ba13276d944f2b7666e8dbe30604ac585a65fbbdba90093753dcd68ec179161a6547e84d6765e4411ba731c5d0c7dfe96d4a60e8da67895818b537b13e3822f922c52b0f65704a1cfc39b5082ac647be15d24a0721387838df59e80971ccacb0950cb3451eb94325374912a819b6c1baab719580ca464b2fa215cb8ea7d7cbf9e10ef78fe713f0fceb7850ff51a66b97e842927c13d25c8fc2610351e8d4cdd539facb97412df3f7bd67ad1bf8fd2b86f59f53dcc4562fc0defcb3cce903c9bb8157', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3336, 28992, 'Vardenafil', 'Grapefruit juice may increase the plasma concentrations of orally administered drugs that are substrates of the CYP450 3A4 isoenzyme.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.  Because grapefruit juice inhibits primarily intestinal rather than hepatic CYP450 3A4, the magnitude of interaction is greatest for those drugs that undergo significant presystemic metabolism by CYP450 3A4 (i.e., drugs with low oral bioavailability). In general, the effect of grapefruit juice is concentration-, dose- and preparation-dependent, and can vary widely among brands.', 'grapefruit juice', 'Moderate', '', 'DDInter', 0, X'789c7d8f4b4e04310c44af52271821311c00b160c96c59ba13276d944f2b7666e8dbe30604ac585a65fbbdba90093753dcd68ec179161a6547e84d6765e4411ba731c5d0c7dfe96d4a60e8da67895818b537b13e3822f922c52b0f65704a1cfc39b5082ac647be15d24a0721387838df59e80971ccacb0950cb3451eb94325374912a819b6c1baab719580ca464b2fa215cb8ea7d7cbf9e10ef78fe713f0fceb7850ff51a66b97e842927c13d25c8fc2610351e8d4cdd539facb97412df3f7bd67ad1bf8fd2b86f59f53dcc4562fc0defcb3cce903c9bb8157', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3337, 28995, 'Vardenafil', 'Grapefruit juice may increase the plasma concentrations of orally administered drugs that are substrates of the CYP450 3A4 isoenzyme.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.  Because grapefruit juice inhibits primarily intestinal rather than hepatic CYP450 3A4, the magnitude of interaction is greatest for those drugs that undergo significant presystemic metabolism by CYP450 3A4 (i.e., drugs with low oral bioavailability). In general, the effect of grapefruit juice is concentration-, dose- and preparation-dependent, and can vary widely among brands.', 'grapefruit juice', 'Moderate', '', 'DDInter', 0, X'789c7d8f4b4e04310c44af52271821311c00b160c96c59ba13276d944f2b7666e8dbe30604ac585a65fbbdba90093753dcd68ec179161a6547e84d6765e4411ba731c5d0c7dfe96d4a60e8da67895818b537b13e3822f922c52b0f65704a1cfc39b5082ac647be15d24a0721387838df59e80971ccacb0950cb3451eb94325374912a819b6c1baab719580ca464b2fa215cb8ea7d7cbf9e10ef78fe713f0fceb7850ff51a66b97e842927c13d25c8fc2610351e8d4cdd539facb97412df3f7bd67ad1bf8fd2b86f59f53dcc4562fc0defcb3cce903c9bb8157', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3338, 29005, 'Vardenafil', 'Grapefruit juice may increase the plasma concentrations of orally administered drugs that are substrates of the CYP450 3A4 isoenzyme.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.  Because grapefruit juice inhibits primarily intestinal rather than hepatic CYP450 3A4, the magnitude of interaction is greatest for those drugs that undergo significant presystemic metabolism by CYP450 3A4 (i.e., drugs with low oral bioavailability). In general, the effect of grapefruit juice is concentration-, dose- and preparation-dependent, and can vary widely among brands.', 'grapefruit juice', 'Moderate', '', 'DDInter', 0, X'789c7d8f4b4e04310c44af52271821311c00b160c96c59ba13276d944f2b7666e8dbe30604ac585a65fbbdba90093753dcd68ec179161a6547e84d6765e4411ba731c5d0c7dfe96d4a60e8da67895818b537b13e3822f922c52b0f65704a1cfc39b5082ac647be15d24a0721387838df59e80971ccacb0950cb3451eb94325374912a819b6c1baab719580ca464b2fa215cb8ea7d7cbf9e10ef78fe713f0fceb7850ff51a66b97e842927c13d25c8fc2610351e8d4cdd539facb97412df3f7bd67ad1bf8fd2b86f59f53dcc4562fc0defcb3cce903c9bb8157', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3339, 29006, 'Vardenafil', 'Grapefruit juice may increase the plasma concentrations of orally administered drugs that are substrates of the CYP450 3A4 isoenzyme.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.  Because grapefruit juice inhibits primarily intestinal rather than hepatic CYP450 3A4, the magnitude of interaction is greatest for those drugs that undergo significant presystemic metabolism by CYP450 3A4 (i.e., drugs with low oral bioavailability). In general, the effect of grapefruit juice is concentration-, dose- and preparation-dependent, and can vary widely among brands.', 'grapefruit juice', 'Moderate', '', 'DDInter', 0, X'789c7d8f4b4e04310c44af52271821311c00b160c96c59ba13276d944f2b7666e8dbe30604ac585a65fbbdba90093753dcd68ec179161a6547e84d6765e4411ba731c5d0c7dfe96d4a60e8da67895818b537b13e3822f922c52b0f65704a1cfc39b5082ac647be15d24a0721387838df59e80971ccacb0950cb3451eb94325374912a819b6c1baab719580ca464b2fa215cb8ea7d7cbf9e10ef78fe713f0fceb7850ff51a66b97e842927c13d25c8fc2610351e8d4cdd539facb97412df3f7bd67ad1bf8fd2b86f59f53dcc4562fc0defcb3cce903c9bb8157', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3340, 29007, 'Vardenafil', 'Grapefruit juice may increase the plasma concentrations of orally administered drugs that are substrates of the CYP450 3A4 isoenzyme.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.  Because grapefruit juice inhibits primarily intestinal rather than hepatic CYP450 3A4, the magnitude of interaction is greatest for those drugs that undergo significant presystemic metabolism by CYP450 3A4 (i.e., drugs with low oral bioavailability). In general, the effect of grapefruit juice is concentration-, dose- and preparation-dependent, and can vary widely among brands.', 'grapefruit juice', 'Moderate', '', 'DDInter', 0, X'789c7d8f4b4e04310c44af52271821311c00b160c96c59ba13276d944f2b7666e8dbe30604ac585a65fbbdba90093753dcd68ec179161a6547e84d6765e4411ba731c5d0c7dfe96d4a60e8da67895818b537b13e3822f922c52b0f65704a1cfc39b5082ac647be15d24a0721387838df59e80971ccacb0950cb3451eb94325374912a819b6c1baab719580ca464b2fa215cb8ea7d7cbf9e10ef78fe713f0fceb7850ff51a66b97e842927c13d25c8fc2610351e8d4cdd539facb97412df3f7bd67ad1bf8fd2b86f59f53dcc4562fc0defcb3cce903c9bb8157', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3341, 29144, 'Vardenafil', 'Grapefruit juice may increase the plasma concentrations of orally administered drugs that are substrates of the CYP450 3A4 isoenzyme.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.  Because grapefruit juice inhibits primarily intestinal rather than hepatic CYP450 3A4, the magnitude of interaction is greatest for those drugs that undergo significant presystemic metabolism by CYP450 3A4 (i.e., drugs with low oral bioavailability). In general, the effect of grapefruit juice is concentration-, dose- and preparation-dependent, and can vary widely among brands.', 'grapefruit juice', 'Moderate', '', 'DDInter', 0, X'789c7d8f4b4e04310c44af52271821311c00b160c96c59ba13276d944f2b7666e8dbe30604ac585a65fbbdba90093753dcd68ec179161a6547e84d6765e4411ba731c5d0c7dfe96d4a60e8da67895818b537b13e3822f922c52b0f65704a1cfc39b5082ac647be15d24a0721387838df59e80971ccacb0950cb3451eb94325374912a819b6c1baab719580ca464b2fa215cb8ea7d7cbf9e10ef78fe713f0fceb7850ff51a66b97e842927c13d25c8fc2610351e8d4cdd539facb97412df3f7bd67ad1bf8fd2b86f59f53dcc4562fc0defcb3cce903c9bb8157', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3342, 29296, 'Vardenafil', 'Grapefruit juice may increase the plasma concentrations of orally administered drugs that are substrates of the CYP450 3A4 isoenzyme.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.  Because grapefruit juice inhibits primarily intestinal rather than hepatic CYP450 3A4, the magnitude of interaction is greatest for those drugs that undergo significant presystemic metabolism by CYP450 3A4 (i.e., drugs with low oral bioavailability). In general, the effect of grapefruit juice is concentration-, dose- and preparation-dependent, and can vary widely among brands.', 'grapefruit juice', 'Moderate', '', 'DDInter', 0, X'789c7d8f4b4e04310c44af52271821311c00b160c96c59ba13276d944f2b7666e8dbe30604ac585a65fbbdba90093753dcd68ec179161a6547e84d6765e4411ba731c5d0c7dfe96d4a60e8da67895818b537b13e3822f922c52b0f65704a1cfc39b5082ac647be15d24a0721387838df59e80971ccacb0950cb3451eb94325374912a819b6c1baab719580ca464b2fa215cb8ea7d7cbf9e10ef78fe713f0fceb7850ff51a66b97e842927c13d25c8fc2610351e8d4cdd539facb97412df3f7bd67ad1bf8fd2b86f59f53dcc4562fc0defcb3cce903c9bb8157', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3343, 31180, 'Vardenafil', 'Grapefruit juice may increase the plasma concentrations of orally administered drugs that are substrates of the CYP450 3A4 isoenzyme.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.  Because grapefruit juice inhibits primarily intestinal rather than hepatic CYP450 3A4, the magnitude of interaction is greatest for those drugs that undergo significant presystemic metabolism by CYP450 3A4 (i.e., drugs with low oral bioavailability). In general, the effect of grapefruit juice is concentration-, dose- and preparation-dependent, and can vary widely among brands.', 'grapefruit juice', 'Moderate', '', 'DDInter', 0, X'789c7d8f4b4e04310c44af52271821311c00b160c96c59ba13276d944f2b7666e8dbe30604ac585a65fbbdba90093753dcd68ec179161a6547e84d6765e4411ba731c5d0c7dfe96d4a60e8da67895818b537b13e3822f922c52b0f65704a1cfc39b5082ac647be15d24a0721387838df59e80971ccacb0950cb3451eb94325374912a819b6c1baab719580ca464b2fa215cb8ea7d7cbf9e10ef78fe713f0fceb7850ff51a66b97e842927c13d25c8fc2610351e8d4cdd539facb97412df3f7bd67ad1bf8fd2b86f59f53dcc4562fc0defcb3cce903c9bb8157', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3344, 32236, 'Vardenafil', 'Grapefruit juice may increase the plasma concentrations of orally administered drugs that are substrates of the CYP450 3A4 isoenzyme.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.  Because grapefruit juice inhibits primarily intestinal rather than hepatic CYP450 3A4, the magnitude of interaction is greatest for those drugs that undergo significant presystemic metabolism by CYP450 3A4 (i.e., drugs with low oral bioavailability). In general, the effect of grapefruit juice is concentration-, dose- and preparation-dependent, and can vary widely among brands.', 'grapefruit juice', 'Moderate', '', 'DDInter', 0, X'789c7d8f4b4e04310c44af52271821311c00b160c96c59ba13276d944f2b7666e8dbe30604ac585a65fbbdba90093753dcd68ec179161a6547e84d6765e4411ba731c5d0c7dfe96d4a60e8da67895818b537b13e3822f922c52b0f65704a1cfc39b5082ac647be15d24a0721387838df59e80971ccacb0950cb3451eb94325374912a819b6c1baab719580ca464b2fa215cb8ea7d7cbf9e10ef78fe713f0fceb7850ff51a66b97e842927c13d25c8fc2610351e8d4cdd539facb97412df3f7bd67ad1bf8fd2b86f59f53dcc4562fc0defcb3cce903c9bb8157', NULL, X'789c6592cd4ec4300c845fc54790762b249607000e881b072e1cddc46d8df253d9e9aecad36397152c704d3233df4cfb2438d3200b37785f3810645c814b1042256813c19c503342a8255069828d6b51a80354c19456c098b9b036128a106519d564d8008540975e5d429bc0dd1edf5e0e7737707b7f00d64ae563cdd401bc7a90d4b9aa99640a139a65b627c63271cf1eea163ff27da6c8e61c6160d1b69f51d5940dfb9a3669d9f2c6a5c1c938a15f219034b4f350f35c9712d52249ad943f1ebf87309c070ab858fff1ef3a671a577246e1e46359bdc6051358d389c4eb179868b6a9c205f16e03ca38166e4b24afe35ac1b0b5b3aea3adee66305477b1312e07356292b182b2390c1cd0c0bdc06adb674bba286f652f86bee28ebaddd9eac46d82544fdbe7839e2b1e9113f69cb8add71d3cdb14548c2a7df1d23050680efb7f0cfdfd57ec2dc398f780253ad98ce7f34833197c69bbedcac8e188b21a4b24ff83722d23f46277da7d022ee9ed60');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3345, 33836, 'Vardenafil', 'Grapefruit juice may increase the plasma concentrations of orally administered drugs that are substrates of the CYP450 3A4 isoenzyme.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.  Because grapefruit juice inhibits primarily intestinal rather than hepatic CYP450 3A4, the magnitude of interaction is greatest for those drugs that undergo significant presystemic metabolism by CYP450 3A4 (i.e., drugs with low oral bioavailability). In general, the effect of grapefruit juice is concentration-, dose- and preparation-dependent, and can vary widely among brands.', 'grapefruit juice', 'Moderate', '', 'DDInter', 0, X'789c7d8f4b4e04310c44af52271821311c00b160c96c59ba13276d944f2b7666e8dbe30604ac585a65fbbdba90093753dcd68ec179161a6547e84d6765e4411ba731c5d0c7dfe96d4a60e8da67895818b537b13e3822f922c52b0f65704a1cfc39b5082ac647be15d24a0721387838df59e80971ccacb0950cb3451eb94325374912a819b6c1baab719580ca464b2fa215cb8ea7d7cbf9e10ef78fe713f0fceb7850ff51a66b97e842927c13d25c8fc2610351e8d4cdd539facb97412df3f7bd67ad1bf8fd2b86f59f53dcc4562fc0defcb3cce903c9bb8157', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3346, 33837, 'Vardenafil', 'Grapefruit juice may increase the plasma concentrations of orally administered drugs that are substrates of the CYP450 3A4 isoenzyme.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.  Because grapefruit juice inhibits primarily intestinal rather than hepatic CYP450 3A4, the magnitude of interaction is greatest for those drugs that undergo significant presystemic metabolism by CYP450 3A4 (i.e., drugs with low oral bioavailability). In general, the effect of grapefruit juice is concentration-, dose- and preparation-dependent, and can vary widely among brands.', 'grapefruit juice', 'Moderate', '', 'DDInter', 0, X'789c7d8f4b4e04310c44af52271821311c00b160c96c59ba13276d944f2b7666e8dbe30604ac585a65fbbdba90093753dcd68ec179161a6547e84d6765e4411ba731c5d0c7dfe96d4a60e8da67895818b537b13e3822f922c52b0f65704a1cfc39b5082ac647be15d24a0721387838df59e80971ccacb0950cb3451eb94325374912a819b6c1baab719580ca464b2fa215cb8ea7d7cbf9e10ef78fe713f0fceb7850ff51a66b97e842927c13d25c8fc2610351e8d4cdd539facb97412df3f7bd67ad1bf8fd2b86f59f53dcc4562fc0defcb3cce903c9bb8157', NULL, X'789c6592cd4ec4300c845fc54790762b249607000e881b072e1cddc46d8df253d9e9aecad36397152c704d3233df4cfb2438d3200b37785f3810645c814b1042256813c19c503342a8255069828d6b51a80354c19456c098b9b036128a106519d564d8008540975e5d429bc0dd1edf5e0e7737707b7f00d64ae563cdd401bc7a90d4b9aa99640a139a65b627c63271cf1eea163ff27da6c8e61c6160d1b69f51d5940dfb9a3669d9f2c6a5c1c938a15f219034b4f350f35c9712d52249ad943f1ebf87309c070ab858fff1ef3a671a577246e1e46359bdc6051358d389c4eb179868b6a9c205f16e03ca38166e4b24afe35ac1b0b5b3aea3adee66305477b1312e07356292b182b2390c1cd0c0bdc06adb674bba286f652f86bee28ebaddd9eac46d82544fdbe7839e2b1e9113f69cb8add71d3cdb14548c2a7df1d23050680efb7f0cfdfd57ec2dc398f780253ad98ce7f34833197c69bbedcac8e188b21a4b24ff83722d23f46277da7d022ee9ed60');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3348, 4005, 'Venlafaxine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c1d8ecb0dc3300c4357e100fdcc50f4de4bd101545b49d4d896612901b27deddc04f03d528f1474d1844c07aa3a171772866966e8045f1875a1962968d25902789a38b88df0f97a5f29b8ec0c9abb6937e0630c29089abf52c845cb59ddd8b6e423a118e55442371a25146ebb6e063bcc392372edb00d914abc6b83e44ad272c7c7e86f8bf3b82ffd3729ab94f93240543bc2a259bd1bb64a4a76fb0301fd51b0');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3349, 4006, 'Venlafaxine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c1d8ecb0dc3300c4357e100fdcc50f4de4bd101545b49d4d896612901b27deddc04f03d528f1474d1844c07aa3a171772866966e8045f1875a1962968d25902789a38b88df0f97a5f29b8ec0c9abb6937e0630c29089abf52c845cb59ddd8b6e423a118e55442371a25146ebb6e063bcc392372edb00d914abc6b83e44ad272c7c7e86f8bf3b82ffd3729ab94f93240543bc2a259bd1bb64a4a76fb0301fd51b0');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3350, 4010, 'Venlafaxine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c1d8ecb0dc3300c4357e100fdcc50f4de4bd101545b49d4d896612901b27deddc04f03d528f1474d1844c07aa3a171772866966e8045f1875a1962968d25902789a38b88df0f97a5f29b8ec0c9abb6937e0630c29089abf52c845cb59ddd8b6e423a118e55442371a25146ebb6e063bcc392372edb00d914abc6b83e44ad272c7c7e86f8bf3b82ffd3729ab94f93240543bc2a259bd1bb64a4a76fb0301fd51b0');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3351, 6386, 'Venlafaxine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c1d8ecb0dc3300c4357e100fdcc50f4de4bd101545b49d4d896612901b27deddc04f03d528f1474d1844c07aa3a171772866966e8045f1875a1962968d25902789a38b88df0f97a5f29b8ec0c9abb6937e0630c29089abf52c845cb59ddd8b6e423a118e55442371a25146ebb6e063bcc392372edb00d914abc6b83e44ad272c7c7e86f8bf3b82ffd3729ab94f93240543bc2a259bd1bb64a4a76fb0301fd51b0');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3352, 12174, 'Venlafaxine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c1d8ecb0dc3300c4357e100fdcc50f4de4bd101545b49d4d896612901b27deddc04f03d528f1474d1844c07aa3a171772866966e8045f1875a1962968d25902789a38b88df0f97a5f29b8ec0c9abb6937e0630c29089abf52c845cb59ddd8b6e423a118e55442371a25146ebb6e063bcc392372edb00d914abc6b83e44ad272c7c7e86f8bf3b82ffd3729ab94f93240543bc2a259bd1bb64a4a76fb0301fd51b0');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3353, 17234, 'Venlafaxine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c1d8ecb0dc3300c4357e100fdcc50f4de4bd101545b49d4d896612901b27deddc04f03d528f1474d1844c07aa3a171772866966e8045f1875a1962968d25902789a38b88df0f97a5f29b8ec0c9abb6937e0630c29089abf52c845cb59ddd8b6e423a118e55442371a25146ebb6e063bcc392372edb00d914abc6b83e44ad272c7c7e86f8bf3b82ffd3729ab94f93240543bc2a259bd1bb64a4a76fb0301fd51b0');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3354, 17235, 'Venlafaxine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c1d8ecb0dc3300c4357e100fdcc50f4de4bd101545b49d4d896612901b27deddc04f03d528f1474d1844c07aa3a171772866966e8045f1875a1962968d25902789a38b88df0f97a5f29b8ec0c9abb6937e0630c29089abf52c845cb59ddd8b6e423a118e55442371a25146ebb6e063bcc392372edb00d914abc6b83e44ad272c7c7e86f8bf3b82ffd3729ab94f93240543bc2a259bd1bb64a4a76fb0301fd51b0');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3355, 17236, 'Venlafaxine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c1d8ecb0dc3300c4357e100fdcc50f4de4bd101545b49d4d896612901b27deddc04f03d528f1474d1844c07aa3a171772866966e8045f1875a1962968d25902789a38b88df0f97a5f29b8ec0c9abb6937e0630c29089abf52c845cb59ddd8b6e423a118e55442371a25146ebb6e063bcc392372edb00d914abc6b83e44ad272c7c7e86f8bf3b82ffd3729ab94f93240543bc2a259bd1bb64a4a76fb0301fd51b0');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3356, 18100, 'Venlafaxine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c1d8ecb0dc3300c4357e100fdcc50f4de4bd101545b49d4d896612901b27deddc04f03d528f1474d1844c07aa3a171772866966e8045f1875a1962968d25902789a38b88df0f97a5f29b8ec0c9abb6937e0630c29089abf52c845cb59ddd8b6e423a118e55442371a25146ebb6e063bcc392372edb00d914abc6b83e44ad272c7c7e86f8bf3b82ffd3729ab94f93240543bc2a259bd1bb64a4a76fb0301fd51b0');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3357, 18106, 'Venlafaxine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c1d8ecb0dc3300c4357e100fdcc50f4de4bd101545b49d4d896612901b27deddc04f03d528f1474d1844c07aa3a171772866966e8045f1875a1962968d25902789a38b88df0f97a5f29b8ec0c9abb6937e0630c29089abf52c845cb59ddd8b6e423a118e55442371a25146ebb6e063bcc392372edb00d914abc6b83e44ad272c7c7e86f8bf3b82ffd3729ab94f93240543bc2a259bd1bb64a4a76fb0301fd51b0');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3358, 19873, 'Venlafaxine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c1d8ecb0dc3300c4357e100fdcc50f4de4bd101545b49d4d896612901b27deddc04f03d528f1474d1844c07aa3a171772866966e8045f1875a1962968d25902789a38b88df0f97a5f29b8ec0c9abb6937e0630c29089abf52c845cb59ddd8b6e423a118e55442371a25146ebb6e063bcc392372edb00d914abc6b83e44ad272c7c7e86f8bf3b82ffd3729ab94f93240543bc2a259bd1bb64a4a76fb0301fd51b0');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3359, 19874, 'Venlafaxine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c1d8ecb0dc3300c4357e100fdcc50f4de4bd101545b49d4d896612901b27deddc04f03d528f1474d1844c07aa3a171772866966e8045f1875a1962968d25902789a38b88df0f97a5f29b8ec0c9abb6937e0630c29089abf52c845cb59ddd8b6e423a118e55442371a25146ebb6e063bcc392372edb00d914abc6b83e44ad272c7c7e86f8bf3b82ffd3729ab94f93240543bc2a259bd1bb64a4a76fb0301fd51b0');